<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Res Protoc</journal-id><journal-id journal-id-type="iso-abbrev">JMIR Res Protoc</journal-id><journal-id journal-id-type="publisher-id">ResProt</journal-id><journal-title-group><journal-title>JMIR Research Protocols</journal-title></journal-title-group><issn pub-type="epub">1929-0748</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28292741</article-id><article-id pub-id-type="pmc">5373675</article-id><article-id pub-id-type="publisher-id">v6i3e42</article-id><article-id pub-id-type="doi">10.2196/resprot.7151</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protocol</subject></subj-group><subj-group subj-group-type="article-type"><subject>Protocol</subject></subj-group></article-categories><title-group><article-title>Writing for Health: Rationale and Protocol for a Randomized Controlled Trial of Internet-Based Benefit-Finding Writing for Adults With Type 1 or Type 2 Diabetes</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Keepanasseril</surname><given-names>Arun</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Lee</surname><given-names>Jae-Ho</given-names></name></contrib><contrib contrib-type="reviewer"><name><surname>Bateman</surname><given-names>Andrew</given-names></name></contrib></contrib-group><contrib-group><contrib id="contrib1" contrib-type="author" corresp="yes"><name><surname>Crawford</surname><given-names>Joanna</given-names></name><degrees>MPsych</degrees><xref ref-type="aff" rid="aff1">1</xref><address><institution>Faces in the Street</institution><institution>Urban Mental Health Research Institute</institution><institution>St. Vincent's Health Australia</institution><addr-line>Level 6, O'Brien Centre, St Vincent's Hospital</addr-line><addr-line>394 Victoria Street, Darlinghurst</addr-line><addr-line>Sydney, 2010</addr-line><country>Australia</country><phone>61 2 8382 1660</phone><fax>61 2 8382 1402</fax><email>Joanna.Crawford@svha.org.au</email></address><xref ref-type="aff" rid="aff2">2</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4947-1626</contrib-id></contrib><contrib id="contrib2" contrib-type="author"><name><surname>Wilhelm</surname><given-names>Kay</given-names></name><degrees>MBBS, MD, FRANZCP</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8542-6478</contrib-id></contrib><contrib id="contrib3" contrib-type="author"><name><surname>Robins</surname><given-names>Lisa</given-names></name><degrees>MPsych</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0288-1564</contrib-id></contrib><contrib id="contrib4" contrib-type="author"><name><surname>Proudfoot</surname><given-names>Judy</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3872-9871</contrib-id></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Faces in the Street</institution><institution>Urban Mental Health Research Institute</institution><institution>St. Vincent's Health Australia</institution><addr-line>Sydney</addr-line><country>Australia</country></aff><aff id="aff2"><sup>2</sup><institution>School of Psychiatry</institution><institution>Faculty of Medicine</institution><institution>University of New South Wales</institution><addr-line>Sydney</addr-line><country>Australia</country></aff><aff id="aff3"><sup>3</sup><institution>Consultation Liaison Psychiatry</institution><institution>St. Vincent's Health Australia</institution><addr-line>Sydney</addr-line><country>Australia</country></aff><aff id="aff4"><sup>4</sup><institution>Black Dog Institute</institution><addr-line>Sydney</addr-line><country>Australia</country></aff><author-notes><corresp>Corresponding Author: Joanna Crawford
<email>Joanna.Crawford@svha.org.au</email></corresp></author-notes><pub-date pub-type="collection"><month>3</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>14</day><month>3</month><year>2017</year></pub-date><volume>6</volume><issue>3</issue><elocation-id>e42</elocation-id><history><date date-type="received"><day>12</day><month>12</month><year>2016</year></date><date date-type="rev-request"><day>10</day><month>1</month><year>2017</year></date><date date-type="rev-recd"><day>15</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>16</day><month>1</month><year>2017</year></date></history><permissions><copyright-statement>©Joanna Crawford, Kay Wilhelm, Lisa Robins, Judy Proudfoot. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 14.03.2017.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0/">http://creativecommons.org/licenses/by/2.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="http://www.researchprotocols.org,">http://www.researchprotocols.org,</ext-link> as well as this copyright and license information must be included.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="http://www.researchprotocols.org/2017/3/e42/"></self-uri><abstract><sec sec-type="background"><title><offsets xml_i="6153" xml_f="6163" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="6174" xml_f="7118" txt_i="22" txt_f="966">Diabetes mellitus is Australia’s fastest growing chronic disease, and has high comorbidity with depression. Both subthreshold depression and diabetes distress are common amongst people with type 1 or type 2 diabetes, and are associated with poorer diabetes self-care. A need exists for low-intensity self-help interventions for large numbers of people with diabetes and diabetes distress or subthreshold depression, as part of a stepped-care approach to meeting the psychological needs of people with diabetes. Benefit-finding writing is a very brief intervention that involves writing about any positive thoughts and feelings about a stressful experience, such as an illness. Benefit-finding writing has been associated with increases in positive affect and positive growth, and has demonstrated promising results in trials amongst other clinical populations. However, benefit-finding writing has not yet been examined in people with diabetes.</offsets></p></sec><sec sec-type="objective"><title><offsets xml_i="7161" xml_f="7170" txt_i="968" txt_f="977">Objective</offsets></title><p><offsets xml_i="7181" xml_f="7532" txt_i="978" txt_f="1329">The aim of this randomized controlled trial (RCT) is to evaluate the efficacy of an Internet-based benefit-finding writing (iBFW) intervention for adults with type 1 or type 2 diabetes (compared to a control writing condition) for reducing diabetes distress and increasing benefit-finding in diabetes, and also improving a range of secondary outcomes.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="7573" xml_f="7580" txt_i="1331" txt_f="1338">Methods</offsets></title><p><offsets xml_i="7591" xml_f="8373" txt_i="1339" txt_f="2121">A two-arm RCT will be conducted, using the online program Writing for Health. Adults with type 1 or type 2 diabetes living in Australia will be recruited using diabetes-related publications and websites, and through advertisements in diabetes services and general practitioners’ offices. Potential participants will be referred to the study-specific website for participant information and screening. All data will be collected online. Participants will be randomized to either iBFW about diabetes, or a control writing condition of writing about use-of-time. Both conditions involve three daily sessions (once per day for three consecutive days) of 15-minute online writing exercises. Outcome measures will be administered online at baseline, one-month, and three-month follow-ups.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="8414" xml_f="8421" txt_i="2123" txt_f="2130">Results</offsets></title><p><offsets xml_i="8432" xml_f="9045" txt_i="2131" txt_f="2744">This trial is currently underway. The primary outcomes will be diabetes distress and benefit-finding in diabetes. Secondary outcomes will be depression, anxiety, diabetes self-care, perceived health, and health care utilization. We aim to recruit 104 participants. All stages of the study will be conducted online using the Writing for Health program. Group differences will be analyzed on an intention-to-treat basis using mixed models repeated measures. Linguistic analyses of the writing exercise scripts, and examinations of the immediate emotional responses to the writing exercises, will also be undertaken.</offsets></p></sec><sec sec-type="conclusions"><title><offsets xml_i="9090" xml_f="9101" txt_i="2746" txt_f="2757">Conclusions</offsets></title><p><offsets xml_i="9112" xml_f="9459" txt_i="2758" txt_f="3105">This RCT will be the first study to examine iBFW for adults with type 1 or type 2 diabetes. If iBFW is found to be efficacious in reducing diabetes distress and improving diabetes self-care and other outcomes, iBFW may offer the potential to be a low-cost, easily accessible self-help intervention to improve the wellbeing of adults with diabetes.</offsets></p></sec><sec sec-type="Trial Registration"><title><offsets xml_i="9511" xml_f="9529" txt_i="3107" txt_f="3125">Trial Registration</offsets></title><p><offsets xml_i="9540" xml_f="9612" txt_i="3126" txt_f="3198">Australia and New Zealand Clinical Trials Registry (ACTRN12615000241538)</offsets></p></sec></abstract><kwd-group><kwd>type 1 diabetes</kwd><kwd>type 2 diabetes</kwd><kwd>diabetes-related distress</kwd><kwd>writing</kwd><kwd>Internet intervention</kwd><kwd>randomized controlled trial</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction"><title><offsets xml_i="9897" xml_f="9909" txt_i="3207" txt_f="3219">Introduction</offsets></title><sec><title><offsets xml_i="9929" xml_f="9939" txt_i="3220" txt_f="3230">Background</offsets></title><sec><title><offsets xml_i="9959" xml_f="10035" txt_i="3231" txt_f="3307">Need for Cost-Effective Psychological Interventions for People with Diabetes</offsets></title><p><offsets xml_i="10046" xml_f="10158" txt_i="3308" txt_f="3420">Diabetes mellitus is a global public health challenge. Diabetes is a leading cause of disease burden worldwide [</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="10191" xml_f="10192" txt_i="3420" txt_f="3421">1</offsets></xref><offsets xml_i="10199" xml_f="10296" txt_i="3421" txt_f="3518">] and is increasing in prevalence, with an estimated 422 million adults having diabetes in 2014 [</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="10329" xml_f="10330" txt_i="3518" txt_f="3519">2</offsets></xref><offsets xml_i="10337" xml_f="10559" txt_i="3519" txt_f="3741">]. The cooccurrence of diabetes and depression is common, with the prevalence rates of depression and anxiety at least twice as high in patients with type 1 or type 2 diabetes compared to the general population worldwide [</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="10592" xml_f="10593" txt_i="3741" txt_f="3742">3</offsets></xref><offsets xml_i="10600" xml_f="10601" txt_i="3742" txt_f="3743">-</offsets><xref rid="ref5" ref-type="bibr"><offsets xml_i="10634" xml_f="10635" txt_i="3743" txt_f="3744">5</offsets></xref><offsets xml_i="10642" xml_f="10706" txt_i="3744" txt_f="3808">]. Depression is associated with poor diabetes self-management [</offsets><xref rid="ref6" ref-type="bibr"><offsets xml_i="10739" xml_f="10740" txt_i="3808" txt_f="3809">6</offsets></xref><offsets xml_i="10747" xml_f="10748" txt_i="3809" txt_f="3810">,</offsets><xref rid="ref7" ref-type="bibr"><offsets xml_i="10781" xml_f="10782" txt_i="3810" txt_f="3811">7</offsets></xref><offsets xml_i="10789" xml_f="10853" txt_i="3811" txt_f="3875">] and increased disease severity, complications, and mortality [</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="10886" xml_f="10887" txt_i="3875" txt_f="3876">8</offsets></xref><offsets xml_i="10894" xml_f="10895" txt_i="3876" txt_f="3877">,</offsets><xref rid="ref9" ref-type="bibr"><offsets xml_i="10928" xml_f="10929" txt_i="3877" txt_f="3878">9</offsets></xref><offsets xml_i="10936" xml_f="11291" txt_i="3878" txt_f="4233">]. Subthreshold depression (clinically significant symptoms of depression that do not meet diagnostic criteria for a major depressive episode or dysthymia) is more common in people with diabetes than major depression, with approximately half of all adults with type 2 diabetes experiencing at least one episode of subthreshold depression over five years [</offsets><xref rid="ref9" ref-type="bibr"><offsets xml_i="11324" xml_f="11325" txt_i="4233" txt_f="4234">9</offsets></xref><offsets xml_i="11332" xml_f="11419" txt_i="4234" txt_f="4321">]. Even subthreshold depression in diabetes is associated with poorer quality of life [</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="11453" xml_f="11455" txt_i="4321" txt_f="4323">10</offsets></xref><offsets xml_i="11462" xml_f="11552" txt_i="4323" txt_f="4413">] and reduced adherence to diabetes self-care (including exercise, diet, and medication) [</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="11586" xml_f="11588" txt_i="4413" txt_f="4415">11</offsets></xref><offsets xml_i="11595" xml_f="11662" txt_i="4415" txt_f="4482">], in addition to being a risk factor for future major depression [</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="11696" xml_f="11698" txt_i="4482" txt_f="4484">12</offsets></xref><offsets xml_i="11705" xml_f="11707" txt_i="4484" txt_f="4486">].</offsets></p><p><offsets xml_i="11714" xml_f="11887" txt_i="4487" txt_f="4660">Diabetes distress is a construct partly overlapping with depression in people with diabetes, and includes negative thoughts and emotions towards diabetes and its treatment [</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="11921" xml_f="11923" txt_i="4660" txt_f="4662">13</offsets></xref><offsets xml_i="11930" xml_f="12015" txt_i="4662" txt_f="4747">]. Approximately 10-30% of people with diabetes experience severe diabetes distress [</offsets><xref rid="ref14" ref-type="bibr"><offsets xml_i="12049" xml_f="12051" txt_i="4747" txt_f="4749">14</offsets></xref><offsets xml_i="12058" xml_f="12059" txt_i="4749" txt_f="4750">,</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="12093" xml_f="12095" txt_i="4750" txt_f="4752">15</offsets></xref><offsets xml_i="12102" xml_f="12315" txt_i="4752" txt_f="4965">], yet many of these people are not clinically depressed. Approximately 70% of people with type 2 diabetes display high levels of diabetes-related distress without meeting criteria for major depressive disorders [</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="12349" xml_f="12351" txt_i="4965" txt_f="4967">16</offsets></xref><offsets xml_i="12358" xml_f="12359" txt_i="4967" txt_f="4968">,</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="12393" xml_f="12395" txt_i="4968" txt_f="4970">17</offsets></xref><offsets xml_i="12402" xml_f="12525" txt_i="4970" txt_f="5093">]. Diabetes distress is associated with poor glycemic control, acting as a unique contributor to poor self-care adherence [</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="12559" xml_f="12561" txt_i="5093" txt_f="5095">18</offsets></xref><offsets xml_i="12568" xml_f="12669" txt_i="5095" txt_f="5196">]. Diabetes distress is also a risk factor for the incidence and persistence of depressive symptoms [</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="12703" xml_f="12705" txt_i="5196" txt_f="5198">19</offsets></xref><offsets xml_i="12712" xml_f="12714" txt_i="5198" txt_f="5200">].</offsets></p><p><offsets xml_i="12721" xml_f="12921" txt_i="5201" txt_f="5401">Thus, international guidelines for diabetes management now recognize the importance of psychological care, not only to improve quality of life, but also diabetes self-management and medical outcomes [</offsets><xref rid="ref20" ref-type="bibr"><offsets xml_i="12955" xml_f="12957" txt_i="5401" txt_f="5403">20</offsets></xref><offsets xml_i="12964" xml_f="13081" txt_i="5403" txt_f="5520">]. Screening for both depression and diabetes distress, followed by appropriate interventions, has been recommended [</offsets><xref rid="ref21" ref-type="bibr"><offsets xml_i="13115" xml_f="13117" txt_i="5520" txt_f="5522">21</offsets></xref><offsets xml_i="13124" xml_f="13125" txt_i="5522" txt_f="5523">,</offsets><xref rid="ref22" ref-type="bibr"><offsets xml_i="13159" xml_f="13161" txt_i="5523" txt_f="5525">22</offsets></xref><offsets xml_i="13168" xml_f="13399" txt_i="5525" txt_f="5756">]. A stepped-care approach to the management of depression in people with diabetes has been suggested, with mild or subthreshold symptoms of depression managed within primary care, utilizing evidence-based self-help interventions [</offsets><xref rid="ref23" ref-type="bibr"><offsets xml_i="13433" xml_f="13435" txt_i="5756" txt_f="5758">23</offsets></xref><offsets xml_i="13442" xml_f="13666" txt_i="5758" txt_f="5982">]. This approach is in line with recommendations by the UK National Health Service, and Diabetes UK, for low-intensity psychological interventions to be used for people with diabetes with lower-level depression or distress [</offsets><xref rid="ref24" ref-type="bibr"><offsets xml_i="13700" xml_f="13702" txt_i="5982" txt_f="5984">24</offsets></xref><offsets xml_i="13709" xml_f="13711" txt_i="5984" txt_f="5986">].</offsets></p><p><offsets xml_i="13718" xml_f="14133" txt_i="5987" txt_f="6402">Given the large numbers of people affected by diabetes globally, accessibility and cost-effectiveness are key issues in their psychological care. The Internet is an increasingly popular and cost-effective method of increasing access to evidence-based psychological interventions, and overcomes several of the traditional barriers to accessing mental health care, such as cost and concerns about stigma and privacy [</offsets><xref rid="ref25" ref-type="bibr"><offsets xml_i="14167" xml_f="14169" txt_i="6402" txt_f="6404">25</offsets></xref><offsets xml_i="14176" xml_f="14263" txt_i="6404" txt_f="6491">]. The Internet offers great potential for public health and prevention interventions [</offsets><xref rid="ref25" ref-type="bibr"><offsets xml_i="14297" xml_f="14299" txt_i="6491" txt_f="6493">25</offsets></xref><offsets xml_i="14306" xml_f="14459" txt_i="6493" txt_f="6646">]. For people with diabetes, Internet-based programs have demonstrated user acceptability and potential efficacy for improving diabetes self-management [</offsets><xref rid="ref26" ref-type="bibr"><offsets xml_i="14493" xml_f="14495" txt_i="6646" txt_f="6648">26</offsets></xref><offsets xml_i="14502" xml_f="14503" txt_i="6648" txt_f="6649">,</offsets><xref rid="ref27" ref-type="bibr"><offsets xml_i="14537" xml_f="14539" txt_i="6649" txt_f="6651">27</offsets></xref><offsets xml_i="14546" xml_f="14618" txt_i="6651" txt_f="6723">], and efficacy in reducing depression, anxiety, and diabetes distress [</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="14652" xml_f="14654" txt_i="6723" txt_f="6725">28</offsets></xref><offsets xml_i="14661" xml_f="14662" txt_i="6725" txt_f="6726">-</offsets><xref rid="ref30" ref-type="bibr"><offsets xml_i="14696" xml_f="14698" txt_i="6726" txt_f="6728">30</offsets></xref><offsets xml_i="14705" xml_f="14945" txt_i="6728" txt_f="6968">]. Therefore, brief, Internet-based interventions have the potential to offer low-cost assistance to large numbers of people with diabetes who are experiencing mild or subthreshold psychological symptoms, as part of a stepped-care approach.</offsets></p></sec><sec><title><offsets xml_i="14967" xml_f="15022" txt_i="6970" txt_f="7025">Evolution of Expressive Writing as a Brief Intervention</offsets></title><p><offsets xml_i="15033" xml_f="15125" txt_i="7026" txt_f="7118">Therapeutic writing is a brief intervention that aims to improve physical or mental health [</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="15159" xml_f="15161" txt_i="7118" txt_f="7120">31</offsets></xref><offsets xml_i="15168" xml_f="15410" txt_i="7120" txt_f="7362">]. The most common form of therapeutic writing is expressive writing (EW), in which thoughts and feelings regarding a stressful event are disclosed in writing, typically for 15-20 minutes for three to four days within a short period of time [</offsets><xref rid="ref32" ref-type="bibr"><offsets xml_i="15444" xml_f="15446" txt_i="7362" txt_f="7364">32</offsets></xref><offsets xml_i="15453" xml_f="15768" txt_i="7364" txt_f="7679">]. EW has been examined in over 250 studies investigating its effects on physical and/or mental health in a wide range of populations, including healthy participants, people with psychological problems, or people with long-term health conditions such as chronic pain, asthma, cancer, cystic fibrosis, or arthritis [</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="15802" xml_f="15804" txt_i="7679" txt_f="7681">31</offsets></xref><offsets xml_i="15811" xml_f="15812" txt_i="7681" txt_f="7682">,</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="15846" xml_f="15848" txt_i="7682" txt_f="7684">33</offsets></xref><offsets xml_i="15855" xml_f="15933" txt_i="7684" txt_f="7762">]. Mental health benefits of EW have included reduced symptoms of depression [</offsets><xref rid="ref34" ref-type="bibr"><offsets xml_i="15967" xml_f="15969" txt_i="7762" txt_f="7764">34</offsets></xref><offsets xml_i="15976" xml_f="15977" txt_i="7764" txt_f="7765">,</offsets><xref rid="ref35" ref-type="bibr"><offsets xml_i="16011" xml_f="16013" txt_i="7765" txt_f="7767">35</offsets></xref><offsets xml_i="16020" xml_f="16032" txt_i="7767" txt_f="7779">], anxiety [</offsets><xref rid="ref36" ref-type="bibr"><offsets xml_i="16066" xml_f="16068" txt_i="7779" txt_f="7781">36</offsets></xref><offsets xml_i="16075" xml_f="16104" txt_i="7781" txt_f="7810">], and posttraumatic stress [</offsets><xref rid="ref37" ref-type="bibr"><offsets xml_i="16138" xml_f="16140" txt_i="7810" txt_f="7812">37</offsets></xref><offsets xml_i="16147" xml_f="16148" txt_i="7812" txt_f="7813">,</offsets><xref rid="ref38" ref-type="bibr"><offsets xml_i="16182" xml_f="16184" txt_i="7813" txt_f="7815">38</offsets></xref><offsets xml_i="16191" xml_f="16282" txt_i="7815" txt_f="7906">]. Physical health benefits of EW have included improved lung function in asthma patients [</offsets><xref rid="ref39" ref-type="bibr"><offsets xml_i="16316" xml_f="16318" txt_i="7906" txt_f="7908">39</offsets></xref><offsets xml_i="16325" xml_f="16410" txt_i="7908" txt_f="7993">], improved immune function in patients with human immunodeficiency virus infection [</offsets><xref rid="ref40" ref-type="bibr"><offsets xml_i="16444" xml_f="16446" txt_i="7993" txt_f="7995">40</offsets></xref><offsets xml_i="16453" xml_f="16531" txt_i="7995" txt_f="8073">], and reduced fatigue and pain in adults with lupus or rheumatoid arthritis [</offsets><xref rid="ref41" ref-type="bibr"><offsets xml_i="16565" xml_f="16567" txt_i="8073" txt_f="8075">41</offsets></xref><offsets xml_i="16574" xml_f="16677" txt_i="8075" txt_f="8178">]. Evidence for behavioral change following EW also exists, such as decreased health care utilization [</offsets><xref rid="ref32" ref-type="bibr"><offsets xml_i="16711" xml_f="16713" txt_i="8178" txt_f="8180">32</offsets></xref><offsets xml_i="16720" xml_f="16721" txt_i="8180" txt_f="8181">,</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="16755" xml_f="16757" txt_i="8181" txt_f="8183">42</offsets></xref><offsets xml_i="16764" xml_f="16802" txt_i="8183" txt_f="8221">], reduced aggression in adolescents [</offsets><xref rid="ref43" ref-type="bibr"><offsets xml_i="16836" xml_f="16838" txt_i="8221" txt_f="8223">43</offsets></xref><offsets xml_i="16845" xml_f="16879" txt_i="8223" txt_f="8257">], and improved exam performance [</offsets><xref rid="ref44" ref-type="bibr"><offsets xml_i="16913" xml_f="16915" txt_i="8257" txt_f="8259">44</offsets></xref><offsets xml_i="16922" xml_f="16988" txt_i="8259" txt_f="8325">]. Several reviews and meta-analyses of EW studies are available [</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="17022" xml_f="17024" txt_i="8325" txt_f="8327">31</offsets></xref><offsets xml_i="17031" xml_f="17032" txt_i="8327" txt_f="8328">,</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="17066" xml_f="17068" txt_i="8328" txt_f="8330">33</offsets></xref><offsets xml_i="17075" xml_f="17076" txt_i="8330" txt_f="8331">,</offsets><xref rid="ref39" ref-type="bibr"><offsets xml_i="17110" xml_f="17112" txt_i="8331" txt_f="8333">39</offsets></xref><offsets xml_i="17119" xml_f="17120" txt_i="8333" txt_f="8334">,</offsets><xref rid="ref45" ref-type="bibr"><offsets xml_i="17154" xml_f="17156" txt_i="8334" txt_f="8336">45</offsets></xref><offsets xml_i="17163" xml_f="17164" txt_i="8336" txt_f="8337">,</offsets><xref rid="ref46" ref-type="bibr"><offsets xml_i="17198" xml_f="17200" txt_i="8337" txt_f="8339">46</offsets></xref><offsets xml_i="17207" xml_f="17209" txt_i="8339" txt_f="8341">].</offsets></p><p><offsets xml_i="17216" xml_f="17418" txt_i="8342" txt_f="8544">However, there are limitations to EW. Results of EW studies are quite variable, and effect sizes are often small. Meta-analyses of the effects of EW have found overall small effects of EW for distress (</offsets><italic><offsets xml_i="17426" xml_f="17427" txt_i="8544" txt_f="8545">r</offsets></italic><offsets xml_i="17436" xml_f="17444" txt_i="8545" txt_f="8553">=.102) [</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="17478" xml_f="17480" txt_i="8553" txt_f="8555">33</offsets></xref><offsets xml_i="17487" xml_f="17545" txt_i="8555" txt_f="8613">] and physical health in medically ill populations (Cohen </offsets><italic><offsets xml_i="17553" xml_f="17554" txt_i="8613" txt_f="8614">d</offsets></italic><offsets xml_i="17563" xml_f="17570" txt_i="8614" txt_f="8621">=.21) [</offsets><xref rid="ref45" ref-type="bibr"><offsets xml_i="17604" xml_f="17606" txt_i="8621" txt_f="8623">45</offsets></xref><offsets xml_i="17613" xml_f="17653" txt_i="8623" txt_f="8663">]. The mechanisms of EW remain unclear [</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="17687" xml_f="17689" txt_i="8663" txt_f="8665">31</offsets></xref><offsets xml_i="17696" xml_f="17769" txt_i="8665" txt_f="8738">], and tend to differ depending on the exact instructions that are used [</offsets><xref rid="ref47" ref-type="bibr"><offsets xml_i="17803" xml_f="17805" txt_i="8738" txt_f="8740">47</offsets></xref><offsets xml_i="17812" xml_f="17886" txt_i="8740" txt_f="8814">]. Furthermore, EW often involves an immediate increase in negative mood [</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="17920" xml_f="17922" txt_i="8814" txt_f="8816">31</offsets></xref><offsets xml_i="17929" xml_f="17990" txt_i="8816" txt_f="8877">], even when followed by longer-term psychological benefits [</offsets><xref rid="ref46" ref-type="bibr"><offsets xml_i="18024" xml_f="18026" txt_i="8877" txt_f="8879">46</offsets></xref><offsets xml_i="18033" xml_f="18155" txt_i="8879" txt_f="9001">]. Thus, it has been suggested that EW in vulnerable populations is best undertaken with therapist support and follow-up [</offsets><xref rid="ref46" ref-type="bibr"><offsets xml_i="18189" xml_f="18191" txt_i="9001" txt_f="9003">46</offsets></xref><offsets xml_i="18198" xml_f="18200" txt_i="9003" txt_f="9005">].</offsets></p><p><offsets xml_i="18207" xml_f="18432" txt_i="9006" txt_f="9231">Indeed, pilot trials of EW in people with diabetes have yielded mixed results. A pilot trial of 22 participants with type 1 diabetes randomized to either an EW group (instructed to write about an emotional or stressful topic </offsets><italic><offsets xml_i="18440" xml_f="18459" txt_i="9231" txt_f="9250">related to diabetes</offsets></italic><offsets xml_i="18468" xml_f="18734" txt_i="9250" txt_f="9516"> for 20 minutes each day over four consecutive days) or a control group (instructed to write about factual topics related to diabetes) found that, at three-months follow-up, the EW group experienced less depressive symptoms and fewer incidences of physical illness [</offsets><xref rid="ref48" ref-type="bibr"><offsets xml_i="18768" xml_f="18770" txt_i="9516" txt_f="9518">48</offsets></xref><offsets xml_i="18777" xml_f="18874" txt_i="9518" txt_f="9615">]. The difference between the two groups in mean self-recorded blood glucose levels (effect size </offsets><italic><offsets xml_i="18882" xml_f="18883" txt_i="9615" txt_f="9616">r</offsets></italic><offsets xml_i="18892" xml_f="19008" txt_i="9616" txt_f="9732">=.236) was in the direction of benefit to the EW group, although this difference was not statistically significant [</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="19042" xml_f="19044" txt_i="9732" txt_f="9734">33</offsets></xref><offsets xml_i="19051" xml_f="19190" txt_i="9734" txt_f="9873">]. However, a pilot trial of 41 adults with type 2 diabetes randomized to either EW or neutral writing found that EW was associated with a </offsets><italic><offsets xml_i="19198" xml_f="19207" txt_i="9873" txt_f="9882">worsening</offsets></italic><offsets xml_i="19216" xml_f="19278" txt_i="9882" txt_f="9944"> in depressive symptoms, with no change in diabetes distress [</offsets><xref rid="ref49" ref-type="bibr"><offsets xml_i="19312" xml_f="19314" txt_i="9944" txt_f="9946">49</offsets></xref><offsets xml_i="19321" xml_f="19470" txt_i="9946" txt_f="10095">]. Of note, in the latter study the EW task involved writing about any stressful experience over the past month rather than a diabetes-specific task.</offsets></p><p><offsets xml_i="19477" xml_f="19880" txt_i="10096" txt_f="10499">These findings have led researchers to investigate other variations of therapeutic writing, to maximize benefits and increase positive affect (and reduce distress) during the intervention. By modifying writing instructions, researchers can attempt to increase the likelihood that participants engage in desired cognitive processes, and thereby aim to increase the benefits gained from the writing task [</offsets><xref rid="ref38" ref-type="bibr"><offsets xml_i="19914" xml_f="19916" txt_i="10499" txt_f="10501">38</offsets></xref><offsets xml_i="19923" xml_f="19924" txt_i="10501" txt_f="10502">,</offsets><xref rid="ref47" ref-type="bibr"><offsets xml_i="19958" xml_f="19960" txt_i="10502" txt_f="10504">47</offsets></xref><offsets xml_i="19967" xml_f="19969" txt_i="10504" txt_f="10506">].</offsets></p></sec><sec><title><offsets xml_i="19991" xml_f="20014" txt_i="10508" txt_f="10531">Benefit-Finding Writing</offsets></title><p><offsets xml_i="20025" xml_f="20089" txt_i="10532" txt_f="10596">Benefit-finding writing involves participants writing about any </offsets><italic><offsets xml_i="20097" xml_f="20105" txt_i="10596" txt_f="10604">positive</offsets></italic><offsets xml_i="20114" xml_f="20316" txt_i="10604" txt_f="10806"> thoughts and feelings about a stressful experience, such as an illness. Until recently, research has largely overlooked the utility of positively-focused writing following stressful events or illness [</offsets><xref rid="ref50" ref-type="bibr"><offsets xml_i="20350" xml_f="20352" txt_i="10806" txt_f="10808">50</offsets></xref><offsets xml_i="20359" xml_f="20504" txt_i="10808" txt_f="10953">]. However, there is emerging evidence that the experience of a medical illness often has sequelae that patients view as positive or beneficial [</offsets><xref rid="ref51" ref-type="bibr"><offsets xml_i="20538" xml_f="20540" txt_i="10953" txt_f="10955">51</offsets></xref><offsets xml_i="20547" xml_f="20605" txt_i="10955" txt_f="11013">]. Increased recognition has been given to the concept of </offsets><italic><offsets xml_i="20613" xml_f="20628" txt_i="11013" txt_f="11028">benefit-finding</offsets></italic><offsets xml_i="20637" xml_f="20760" txt_i="11028" txt_f="11151">, defined as, “identifying positive life changes resulting from adversity and negative life stressors, including illness” [</offsets><xref rid="ref52" ref-type="bibr"><offsets xml_i="20794" xml_f="20796" txt_i="11151" txt_f="11153">52</offsets></xref><offsets xml_i="20803" xml_f="20910" txt_i="11153" txt_f="11260">]. Correlated with posttraumatic growth (positive changes in individuals following traumatic life events) [</offsets><xref rid="ref53" ref-type="bibr"><offsets xml_i="20944" xml_f="20946" txt_i="11260" txt_f="11262">53</offsets></xref><offsets xml_i="20953" xml_f="21091" txt_i="11262" txt_f="11400">], benefit-finding has been associated with increased psychosocial wellbeing and decreased depression in a range of clinical populations [</offsets><xref rid="ref52" ref-type="bibr"><offsets xml_i="21125" xml_f="21127" txt_i="11400" txt_f="11402">52</offsets></xref><offsets xml_i="21134" xml_f="21135" txt_i="11402" txt_f="11403">,</offsets><xref rid="ref54" ref-type="bibr"><offsets xml_i="21169" xml_f="21171" txt_i="11403" txt_f="11405">54</offsets></xref><offsets xml_i="21178" xml_f="21213" txt_i="11405" txt_f="11440">], including people with diabetes [</offsets><xref rid="ref55" ref-type="bibr"><offsets xml_i="21247" xml_f="21249" txt_i="11440" txt_f="11442">55</offsets></xref><offsets xml_i="21256" xml_f="21338" txt_i="11442" txt_f="11524">]. Benefit-finding has also been linked with increased optimism, positive affect [</offsets><xref rid="ref56" ref-type="bibr"><offsets xml_i="21372" xml_f="21374" txt_i="11524" txt_f="11526">56</offsets></xref><offsets xml_i="21381" xml_f="21431" txt_i="11526" txt_f="11576">], self-efficacy, and adaptive coping strategies [</offsets><xref rid="ref57" ref-type="bibr"><offsets xml_i="21465" xml_f="21467" txt_i="11576" txt_f="11578">57</offsets></xref><offsets xml_i="21474" xml_f="21647" txt_i="11578" txt_f="11751">]. Benefit-finding in diabetes has been associated with lower symptoms of depression, increased adherence to diabetes self-care, and greater perceived coping effectiveness [</offsets><xref rid="ref55" ref-type="bibr"><offsets xml_i="21681" xml_f="21683" txt_i="11751" txt_f="11753">55</offsets></xref><offsets xml_i="21690" xml_f="21837" txt_i="11753" txt_f="11900">]. Furthermore, benefit-finding amongst parents of children with diabetes has also been associated with better glycemic control in their children [</offsets><xref rid="ref58" ref-type="bibr"><offsets xml_i="21871" xml_f="21873" txt_i="11900" txt_f="11902">58</offsets></xref><offsets xml_i="21880" xml_f="22006" txt_i="11902" txt_f="12028">]. It has therefore been suggested that interventions could be developed to increase benefit-finding in people with diabetes [</offsets><xref rid="ref55" ref-type="bibr"><offsets xml_i="22040" xml_f="22042" txt_i="12028" txt_f="12030">55</offsets></xref><offsets xml_i="22049" xml_f="22051" txt_i="12030" txt_f="12032">].</offsets></p><p><offsets xml_i="22058" xml_f="22369" txt_i="12033" txt_f="12344">Benefit-finding writing aims to improve other outcomes by facilitating increased ongoing benefit-finding in relation to a medical condition or stressor. However, this concept has not yet been examined in people with diabetes. To date, benefit-finding writing has been examined in student and community samples [</offsets><xref rid="ref47" ref-type="bibr"><offsets xml_i="22403" xml_f="22405" txt_i="12344" txt_f="12346">47</offsets></xref><offsets xml_i="22412" xml_f="22413" txt_i="12346" txt_f="12347">,</offsets><xref rid="ref59" ref-type="bibr"><offsets xml_i="22447" xml_f="22449" txt_i="12347" txt_f="12349">59</offsets></xref><offsets xml_i="22456" xml_f="22457" txt_i="12349" txt_f="12350">-</offsets><xref rid="ref61" ref-type="bibr"><offsets xml_i="22491" xml_f="22493" txt_i="12350" txt_f="12352">61</offsets></xref><offsets xml_i="22500" xml_f="22536" txt_i="12352" txt_f="12388">], bereaved undergraduate students [</offsets><xref rid="ref62" ref-type="bibr"><offsets xml_i="22570" xml_f="22572" txt_i="12388" txt_f="12390">62</offsets></xref><offsets xml_i="22579" xml_f="22652" txt_i="12390" txt_f="12463">], participants who had recently experienced a relationship dissolution [</offsets><xref rid="ref50" ref-type="bibr"><offsets xml_i="22686" xml_f="22688" txt_i="12463" txt_f="12465">50</offsets></xref><offsets xml_i="22695" xml_f="22722" txt_i="12465" txt_f="12492">], breast cancer patients [</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="22756" xml_f="22758" txt_i="12492" txt_f="12494">42</offsets></xref><offsets xml_i="22765" xml_f="22815" txt_i="12494" txt_f="12544">], and adults with lupus or rheumatoid arthritis [</offsets><xref rid="ref41" ref-type="bibr"><offsets xml_i="22849" xml_f="22851" txt_i="12544" txt_f="12546">41</offsets></xref><offsets xml_i="22858" xml_f="22860" txt_i="12546" txt_f="12548">].</offsets></p><p><offsets xml_i="22867" xml_f="23037" txt_i="12549" txt_f="12719">Trials in nonclinical populations have found that benefit-finding writing results in less distress and increased positive affect immediately postwriting, compared to EW [</offsets><xref rid="ref60" ref-type="bibr"><offsets xml_i="23071" xml_f="23073" txt_i="12719" txt_f="12721">60</offsets></xref><offsets xml_i="23080" xml_f="23081" txt_i="12721" txt_f="12722">,</offsets><xref rid="ref61" ref-type="bibr"><offsets xml_i="23115" xml_f="23117" txt_i="12722" txt_f="12724">61</offsets></xref><offsets xml_i="23124" xml_f="23213" txt_i="12724" txt_f="12813">]. Benefit-finding writing is associated with greater increases in posttraumatic growth [</offsets><xref rid="ref47" ref-type="bibr"><offsets xml_i="23247" xml_f="23249" txt_i="12813" txt_f="12815">47</offsets></xref><offsets xml_i="23256" xml_f="23328" txt_i="12815" txt_f="12887">], and greater use of cognitive-insight words, compared to standard EW [</offsets><xref rid="ref61" ref-type="bibr"><offsets xml_i="23362" xml_f="23364" txt_i="12887" txt_f="12889">61</offsets></xref><offsets xml_i="23371" xml_f="23373" txt_i="12889" txt_f="12891">].</offsets></p><p><offsets xml_i="23380" xml_f="23486" txt_i="12892" txt_f="12998">Two trials in clinical populations have compared benefit-finding writing with EW, with promising results [</offsets><xref rid="ref41" ref-type="bibr"><offsets xml_i="23520" xml_f="23522" txt_i="12998" txt_f="13000">41</offsets></xref><offsets xml_i="23529" xml_f="23530" txt_i="13000" txt_f="13001">,</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="23564" xml_f="23566" txt_i="13001" txt_f="13003">42</offsets></xref><offsets xml_i="23573" xml_f="23776" txt_i="13003" txt_f="13206">]. In women with early-stage breast cancer, both benefit-finding and expressive-writing groups had significantly fewer medical appointments for cancer-related morbidities, relative to the control group [</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="23810" xml_f="23812" txt_i="13206" txt_f="13208">42</offsets></xref><offsets xml_i="23819" xml_f="23983" txt_i="13208" txt_f="13372">]. In adults with lupus or rheumatoid arthritis, both benefit-finding writing and EW groups had lower fatigue at three months, relative to a control writing group [</offsets><xref rid="ref41" ref-type="bibr"><offsets xml_i="24017" xml_f="24019" txt_i="13372" txt_f="13374">41</offsets></xref><offsets xml_i="24026" xml_f="24174" txt_i="13374" txt_f="13522">]. An interaction with trait anxiety was also found; benefit-finding appeared to be more useful in reducing pain for those with high trait anxiety [</offsets><xref rid="ref41" ref-type="bibr"><offsets xml_i="24208" xml_f="24210" txt_i="13522" txt_f="13524">41</offsets></xref><offsets xml_i="24217" xml_f="24395" txt_i="13524" txt_f="13702">]. Furthermore, the authors noted that all 27 participants in the benefit-finding group were able to write some, “positive thoughts and feelings” about their illness experience [</offsets><xref rid="ref41" ref-type="bibr"><offsets xml_i="24429" xml_f="24431" txt_i="13702" txt_f="13704">41</offsets></xref><offsets xml_i="24438" xml_f="24628" txt_i="13704" txt_f="13894">]. Thus, the limited research on benefit-finding writing to date suggests that it may have the same longer-term health benefits as EW, but with the added advantage of immediate increases in </offsets><italic><offsets xml_i="24636" xml_f="24644" txt_i="13894" txt_f="13902">positive</offsets></italic><offsets xml_i="24653" xml_f="24660" txt_i="13902" txt_f="13909"> affect</offsets></p></sec><sec><title><offsets xml_i="24682" xml_f="24709" txt_i="13911" txt_f="13938">Rationale for Current Study</offsets></title><p><offsets xml_i="24720" xml_f="24797" txt_i="13939" txt_f="14016">EW is a brief, low-cost intervention that can be delivered via the Internet [</offsets><xref rid="ref63" ref-type="bibr"><offsets xml_i="24831" xml_f="24833" txt_i="14016" txt_f="14018">63</offsets></xref><offsets xml_i="24840" xml_f="24841" txt_i="14018" txt_f="14019">-</offsets><xref rid="ref65" ref-type="bibr"><offsets xml_i="24875" xml_f="24877" txt_i="14019" txt_f="14021">65</offsets></xref><offsets xml_i="24884" xml_f="25074" txt_i="14021" txt_f="14211">]. These factors potentially make EW suitable as a short-term, low-intensity intervention to supplement treatment-as-usual for people with diabetes who have lower-level psychological needs [</offsets><xref rid="ref49" ref-type="bibr"><offsets xml_i="25108" xml_f="25110" txt_i="14211" txt_f="14213">49</offsets></xref><offsets xml_i="25117" xml_f="25183" txt_i="14213" txt_f="14279">]. While the results of pilot trials of EW in diabetes are mixed [</offsets><xref rid="ref48" ref-type="bibr"><offsets xml_i="25217" xml_f="25219" txt_i="14279" txt_f="14281">48</offsets></xref><offsets xml_i="25226" xml_f="25227" txt_i="14281" txt_f="14282">,</offsets><xref rid="ref49" ref-type="bibr"><offsets xml_i="25261" xml_f="25263" txt_i="14282" txt_f="14284">49</offsets></xref><offsets xml_i="25270" xml_f="25817" txt_i="14284" txt_f="14831">], benefit-finding writing is a more recent variation of therapeutic writing, which aims to facilitate increased perceptions of positive life changes resulting from adversity and negative life stressors. As outlined above, the limited research on benefit-finding writing suggests that it leads to increases in positive affect and posttraumatic growth, and may have the same physical health benefits as EW in populations with medical conditions. However, benefit-finding writing has not yet been examined in people with diabetes (type 1 or type 2).</offsets></p><p><offsets xml_i="25824" xml_f="26419" txt_i="14832" txt_f="15427">Therefore, the current study aims to examine the feasibility and efficacy of an Internet-based benefit-finding writing (iBFW) intervention for adults with type 1 or type 2 diabetes. We seek to evaluate the efficacy of iBFW (compared to a control writing condition) in reducing diabetes distress and increasing benefit-finding in diabetes, and also in reducing symptoms of depression and anxiety, improving diabetes self-care and self-rated health, and improving health-care utilization. This paper presents the study protocol for this randomized controlled trial (RCT), using the online program </offsets><italic><offsets xml_i="26427" xml_f="26445" txt_i="15427" txt_f="15445">Writing for Health</offsets></italic><offsets xml_i="26454" xml_f="26455" txt_i="15445" txt_f="15446">.</offsets></p></sec></sec><sec><title><offsets xml_i="26483" xml_f="26508" txt_i="15449" txt_f="15474">Study Aims and Hypotheses</offsets></title><p><offsets xml_i="26519" xml_f="26971" txt_i="15475" txt_f="15927">The primary outcomes of this RCT will be the impact of the iBFW, compared to a control writing condition, on diabetes distress and benefit-finding in diabetes. Our primary hypotheses are that adults with type 1 or type 2 diabetes randomized to receive iBFW will demonstrate significantly reduced diabetes distress and significantly increased benefit-finding for diabetes, compared to the control condition, at both one-month and three-month follow-ups.</offsets></p><p><offsets xml_i="26978" xml_f="27493" txt_i="15928" txt_f="16443">Secondary outcomes will include symptoms of depression, symptoms of anxiety, diabetes self-care, health care utilization, and perceived self-health. Our secondary hypotheses are that compared to those in the control condition, the iBFW group will demonstrate significant: (1) reductions in depression symptoms; (2) reductions in anxiety symptoms; (3) increased diabetes self-care; (4) reduced number of visits to health professionals; and (5) improved perceived health, at both one-month and three-month follow-ups.</offsets></p><p><offsets xml_i="27500" xml_f="27984" txt_i="16444" txt_f="16928">This study also aims to examine validation of the intervention instructions by investigating immediate emotional responses to the writing tasks, and the number of positive emotion words and cognitive insight words used in the writing tasks. It is hypothesized that compared to those in the control condition, the iBFW group will (1) show greater increases in positive affect postwriting, and (2) use more positive emotion words and more cognitive insight words than the control group.</offsets></p></sec></sec><sec sec-type="methods"><title><offsets xml_i="28031" xml_f="28038" txt_i="16931" txt_f="16938">Methods</offsets></title><sec><title><offsets xml_i="28058" xml_f="28070" txt_i="16939" txt_f="16951">Study Design</offsets></title><p><offsets xml_i="28081" xml_f="28173" txt_i="16952" txt_f="17044">A 2 (conditions) x 3 (time) RCT design is planned. A flow diagram for the trial is shown in </offsets><xref ref-type="fig" rid="figure1"><offsets xml_i="28208" xml_f="28216" txt_i="17044" txt_f="17052">Figure 1</offsets></xref><offsets xml_i="28223" xml_f="28758" txt_i="17052" txt_f="17587">. Participants will be randomized to either iBFW or an Internet-based control writing condition. Both conditions involve an intervention of 3 days of online writing. Outcomes will be assessed at 3 time points for both groups: baseline, one-month, and three-months postintervention. We will also assess self-rated current mood immediately prior to and following each writing session, and administer three survey questions (assessing how personal, meaningful, and distressing the writing exercise was) after each writing task. An online </offsets><italic><offsets xml_i="28766" xml_f="28788" txt_i="17587" txt_f="17609">Feedback Questionnaire</offsets></italic><offsets xml_i="28797" xml_f="28895" txt_i="17609" txt_f="17707"> to assess user satisfaction and perceived helpfulness will also be administered postintervention.</offsets></p><fig id="figure1" position="float"><label><offsets xml_i="28941" xml_f="28949" txt_i="17708" txt_f="17716">Figure 1</offsets></label><caption><p><offsets xml_i="28969" xml_f="28986" txt_i="17716" txt_f="17733">Study flow chart.</offsets></p></caption><graphic xlink:href="resprot_v6i3e42_fig1"></graphic></fig><fig id="figure2" position="float"><label><offsets xml_i="29101" xml_f="29109" txt_i="17734" txt_f="17742">Figure 2</offsets></label><caption><p><offsets xml_i="29129" xml_f="29178" txt_i="17742" txt_f="17791">Screenshot of the homepage of Writing for Health.</offsets></p></caption><graphic xlink:href="resprot_v6i3e42_fig2"></graphic></fig></sec><sec><title><offsets xml_i="29269" xml_f="29281" txt_i="17793" txt_f="17805">Participants</offsets></title><sec><title><offsets xml_i="29301" xml_f="29312" txt_i="17806" txt_f="17817">Recruitment</offsets></title><p><offsets xml_i="29323" xml_f="29583" txt_i="17818" txt_f="18078">Participants will be recruited online from Australian diabetes-related websites and publications, and from advertisements in waiting rooms of diabetes services and general practitioners (GPs) throughout Australia. Participants will apply for the study via the </offsets><italic><offsets xml_i="29591" xml_f="29609" txt_i="18078" txt_f="18096">Writing for Health</offsets></italic><offsets xml_i="29618" xml_f="29628" txt_i="18096" txt_f="18106"> website [</offsets><xref rid="ref66" ref-type="bibr"><offsets xml_i="29662" xml_f="29664" txt_i="18106" txt_f="18108">66</offsets></xref><offsets xml_i="29671" xml_f="30367" txt_i="18108" txt_f="18804">], where they will complete an automated screening questionnaire (which also provides baseline data) after reading the study information and provide informed consent. Excluded applicants will immediately receive an onscreen message that informs them that the program is not suitable for them, and will provide links to appropriate resources. All potential participants will be provided with feedback on the severity of their depression and anxiety symptoms. Participants who meet eligibility criteria will proceed to online registration with the program, complete further online questionnaires (for further baseline data), be automatically randomized, and then complete the first writing session.</offsets></p></sec><sec><title><offsets xml_i="30389" xml_f="30400" txt_i="18806" txt_f="18817">Eligibility</offsets></title><p><offsets xml_i="30411" xml_f="30466" txt_i="18818" txt_f="18873">The inclusion and exclusion criteria and summarized in </offsets><xref ref-type="boxed-text" rid="box1"><offsets xml_i="30505" xml_f="30514" txt_i="18873" txt_f="18882">Textbox 1</offsets></xref><offsets xml_i="30521" xml_f="30565" txt_i="18882" txt_f="18926">. Screening will be conducted online in the </offsets><italic><offsets xml_i="30573" xml_f="30591" txt_i="18926" txt_f="18944">Writing for Health</offsets></italic><offsets xml_i="30600" xml_f="30792" txt_i="18944" txt_f="19136"> program. If any responses indicate ineligibility, screening will be automatically stopped and the next onscreen page will provide appropriate feedback (including links to relevant resources).</offsets></p><boxed-text id="box1" position="float"><caption><title><offsets xml_i="30851" xml_f="30884" txt_i="19137" txt_f="19170">Inclusion and exclusion criteria.</offsets></title></caption><p><offsets xml_i="30905" xml_f="30924" txt_i="19171" txt_f="19190">Inclusion criteria:</offsets></p><list list-type="bullet"><list-item><p><offsets xml_i="30967" xml_f="30989" txt_i="19191" txt_f="19213">Consent to participate</offsets></p></list-item><list-item><p><offsets xml_i="31019" xml_f="31041" txt_i="19214" txt_f="19236">Aged 18 years or older</offsets></p></list-item><list-item><p><offsets xml_i="31071" xml_f="31090" txt_i="19237" txt_f="19256">Living in Australia</offsets></p></list-item><list-item><p><offsets xml_i="31120" xml_f="31201" txt_i="19257" txt_f="19338">Type 1 or type 2 diabetes, diagnosed by a general practitioner or endocrinologist</offsets></p></list-item><list-item><p><offsets xml_i="31231" xml_f="31271" txt_i="19339" txt_f="19379">Email address and access to the Internet</offsets></p></list-item></list><p><offsets xml_i="31297" xml_f="31316" txt_i="19380" txt_f="19399">Exclusion criteria:</offsets></p><list list-type="bullet"><list-item><p><offsets xml_i="31359" xml_f="31406" txt_i="19400" txt_f="19447">Inability to read or write in English with ease</offsets></p></list-item><list-item><p><offsets xml_i="31436" xml_f="31545" txt_i="19448" txt_f="19551">Patient Health Questionnaire-9 (PHQ-9) score &gt;10 and/or Generalized Anxiety Disorder-7 (GAD-7) score &gt;8</offsets></p></list-item><list-item><p><offsets xml_i="31575" xml_f="31628" txt_i="19552" txt_f="19605">Diagnosis of bipolar disorder or a psychotic disorder</offsets></p></list-item><list-item><p><offsets xml_i="31658" xml_f="31709" txt_i="19606" txt_f="19657">Diagnosis of dementia or another cognitive disorder</offsets></p></list-item><list-item><p><offsets xml_i="31739" xml_f="31768" txt_i="19658" txt_f="19687">Current psychological therapy</offsets></p></list-item></list></boxed-text></sec><sec><title><offsets xml_i="31822" xml_f="31828" txt_i="19689" txt_f="19695">Ethics</offsets></title><p><offsets xml_i="31839" xml_f="32161" txt_i="19696" txt_f="20018">This study protocol has been approved by the Ethics Committee at St. Vincent’s Hospital, Sydney, which is certified by the National Health and Medical Research Council in Australia (HREC/13/SVH/379). This trial was prospectively registered with the Australia and New Zealand Clinical Trials Registry (ACTRN12615000241538).</offsets></p></sec></sec><sec><title><offsets xml_i="32189" xml_f="32213" txt_i="20021" txt_f="20045">Intervention and Control</offsets></title><sec><title><offsets xml_i="32233" xml_f="32251" txt_i="20046" txt_f="20064">Writing for Health</offsets></title><p><offsets xml_i="32262" xml_f="32314" txt_i="20065" txt_f="20117">This RCT will be conducted using the online program </offsets><italic><offsets xml_i="32322" xml_f="32340" txt_i="20117" txt_f="20135">Writing for Health</offsets></italic><offsets xml_i="32349" xml_f="32351" txt_i="20135" txt_f="20137"> [</offsets><xref rid="ref66" ref-type="bibr"><offsets xml_i="32385" xml_f="32387" txt_i="20137" txt_f="20139">66</offsets></xref><italic><offsets xml_i="32402" xml_f="32420" txt_i="20139" txt_f="20157">Writing for Health</offsets></italic><offsets xml_i="32429" xml_f="32708" txt_i="20157" txt_f="20436">, including information about the study, consent to participate, screening questionnaires with automated feedback, participant registration, randomization to one of two conditions, the writing intervention, and follow-up questionnaires. Automated reminder emails will be sent by </offsets><italic><offsets xml_i="32716" xml_f="32734" txt_i="20436" txt_f="20454">Writing for Health</offsets></italic><offsets xml_i="32743" xml_f="32856" txt_i="20454" txt_f="20567"> to participants on each day of the intervention, and when it is time to complete their follow-up questionnaires.</offsets></p><p><italic><offsets xml_i="32871" xml_f="32889" txt_i="20568" txt_f="20586">Writing for Health</offsets></italic><offsets xml_i="32898" xml_f="33325" txt_i="20586" txt_f="21013"> provides minimal clinician assistance. Direct contact between participants and the clinicians will not occur in the standard course of the trial. Psychologists will monitor participant responses and distress levels throughout the intervention, and in accordance with the risk management protocol, will correspond with participants by email and phone to assess any support needed, and refer to appropriate services if required.</offsets></p><p><offsets xml_i="33332" xml_f="33361" txt_i="21014" txt_f="21043">Participants registered with </offsets><italic><offsets xml_i="33369" xml_f="33387" txt_i="21043" txt_f="21061">Writing for Health</offsets></italic><offsets xml_i="33396" xml_f="33689" txt_i="21061" txt_f="21354"> will be randomized to one of two conditions: iBFW or Internet-based use-of-time writing (control condition). Participants from both conditions will continue to receive usual care from their health services. Following randomization, both conditions involve participants writing online (in the </offsets><italic><offsets xml_i="33697" xml_f="33715" txt_i="21354" txt_f="21372">Writing for Health</offsets></italic><offsets xml_i="33724" xml_f="34024" txt_i="21372" txt_f="21672"> program) for 15 minutes once a day, according to instructions provided. There will be three daily 15-minute online writing sessions (once per day for three consecutive days.) A timer on the screen counts down from 15 minutes, to allow participants to keep track of time during their writing session.</offsets></p><p><offsets xml_i="34031" xml_f="34071" txt_i="21673" txt_f="21713">Information provided to participants in </offsets><italic><offsets xml_i="34079" xml_f="34097" txt_i="21713" txt_f="21731">Writing for Health</offsets></italic><offsets xml_i="34106" xml_f="34193" txt_i="21731" txt_f="21818"> describes the aim of this study as investigating whether the writing exercises in the </offsets><italic><offsets xml_i="34201" xml_f="34219" txt_i="21818" txt_f="21836">Writing for Health</offsets></italic><offsets xml_i="34228" xml_f="34510" txt_i="21836" txt_f="22118"> program improve the mental and physical wellbeing of people with diabetes. Participants will be informed that they will be randomized to one of two types of writing exercises, and both types of writing exercises will be described. However, research hypotheses will not be revealed.</offsets></p></sec><sec><title><offsets xml_i="34532" xml_f="34608" txt_i="22120" txt_f="22196">Intervention Condition - Internet-Based Benefit-Finding Writing for Diabetes</offsets></title><p><offsets xml_i="34619" xml_f="34687" txt_i="22197" txt_f="22265">Participants in the iBFW condition will be asked to write about any </offsets><italic><offsets xml_i="34695" xml_f="34703" txt_i="22265" txt_f="22273">positive</offsets></italic><offsets xml_i="34712" xml_f="34815" txt_i="22273" txt_f="22376"> thoughts and feelings that they have had about their experiences with diabetes. The instructions (see </offsets><xref ref-type="app" rid="app1"><offsets xml_i="34847" xml_f="34868" txt_i="22376" txt_f="22397">Multimedia Appendix 1</offsets></xref><offsets xml_i="34875" xml_f="34995" txt_i="22397" txt_f="22517">) are adapted from those used by Stanton and colleagues (2002) in benefit-finding writing for women with breast cancer [</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="35029" xml_f="35031" txt_i="22517" txt_f="22519">42</offsets></xref><offsets xml_i="35038" xml_f="35180" txt_i="22519" txt_f="22661">]. The same instructions will be provided for all three of the writing sessions, consistent with previous studies of benefit-finding writing [</offsets><xref rid="ref41" ref-type="bibr"><offsets xml_i="35214" xml_f="35216" txt_i="22661" txt_f="22663">41</offsets></xref><offsets xml_i="35223" xml_f="35224" txt_i="22663" txt_f="22664">,</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="35258" xml_f="35260" txt_i="22664" txt_f="22666">42</offsets></xref><offsets xml_i="35267" xml_f="35269" txt_i="22666" txt_f="22668">].</offsets></p></sec><sec><title><offsets xml_i="35291" xml_f="35345" txt_i="22670" txt_f="22724">Control Condition - Internet-Based Use-of-Time Writing</offsets></title><p><offsets xml_i="35356" xml_f="36014" txt_i="22725" txt_f="23383">Participants in the control condition will be asked to write in detail about how their time was spent that day (first writing session) and plans for how their time will be spent the following day (second writing session) and week (third writing session). Participants will be instructed to be as objective as possible, and to focus on the facts and details of how their time was spent (or will be spent), and not to focus on their emotions or opinions. Writing about use-of-time is a neutral topic that has been previously used as an active control condition in a trial of EW, and was found to be associated with reduced physical and mental health symptoms [</offsets><xref rid="ref63" ref-type="bibr"><offsets xml_i="36048" xml_f="36050" txt_i="23383" txt_f="23385">63</offsets></xref><offsets xml_i="36057" xml_f="36059" txt_i="23385" txt_f="23387">].</offsets></p></sec></sec><sec><title><offsets xml_i="36087" xml_f="36096" txt_i="23390" txt_f="23399">Procedure</offsets></title><p><offsets xml_i="36107" xml_f="36145" txt_i="23400" txt_f="23438">Potential participants will visit the </offsets><italic><offsets xml_i="36153" xml_f="36171" txt_i="23438" txt_f="23456">Writing for Health</offsets></italic><offsets xml_i="36180" xml_f="36190" txt_i="23456" txt_f="23466"> website [</offsets><xref rid="ref66" ref-type="bibr"><offsets xml_i="36224" xml_f="36226" txt_i="23466" txt_f="23468">66</offsets></xref><offsets xml_i="36233" xml_f="37194" txt_i="23468" txt_f="24429">], read the participant information, and indicate their consent to participate by checking a box. Potential participants will complete screening questionnaires with automated feedback, and if eligible, can then register to participate. Following completion of further online questionnaires, participants will be automatically randomized to one of two conditions: iBFW or control writing. Participants can then proceed to the first session of their 3-day writing intervention (either iBFW or control writing). Immediately before and after each of their three 15-minute writing sessions, participants will be asked to rate their current mood. In addition, following each writing session, participants will be asked to rate how personal, meaningful, and distressing their writing session was that day, and can comment on the writing session if they wish. At the completion of their three-day writing intervention, participants will be asked to complete the online </offsets><italic><offsets xml_i="37202" xml_f="37224" txt_i="24429" txt_f="24451">Feedback Questionnaire</offsets></italic><offsets xml_i="37233" xml_f="37342" txt_i="24451" txt_f="24560">, to assess user satisfaction and perceived helpfulness. Outcome measures will be administered in the online </offsets><italic><offsets xml_i="37350" xml_f="37359" txt_i="24560" txt_f="24569">One-Month</offsets></italic><offsets xml_i="37368" xml_f="37373" txt_i="24569" txt_f="24574"> and </offsets><italic><offsets xml_i="37381" xml_f="37417" txt_i="24574" txt_f="24610">Three-Month Follow-Up Questionnaires</offsets></italic><offsets xml_i="37426" xml_f="37453" txt_i="24610" txt_f="24637"> (in addition to baseline).</offsets></p><p><offsets xml_i="37460" xml_f="37515" txt_i="24638" txt_f="24693">Participants will be sent automatic reminder emails by </offsets><italic><offsets xml_i="37523" xml_f="37541" txt_i="24693" txt_f="24711">Writing for Health</offsets></italic><offsets xml_i="37550" xml_f="37901" txt_i="24711" txt_f="25062"> on day 2 and day 3 of their writing intervention, and also one-month and three-months postintervention, prompting participants to complete their follow-up questionnaires. All participants will be provided with automatic feedback of the range in which they scored on depression and anxiety measures, at baseline, one-month, and three-month follow-ups.</offsets></p></sec><sec><title><offsets xml_i="37923" xml_f="37947" txt_i="25064" txt_f="25088">Risk Management Protocol</offsets></title><p><offsets xml_i="37958" xml_f="38518" txt_i="25089" txt_f="25649">Psychologists will monitor participant responses and distress levels throughout the intervention. Although direct contact with participants will not occur during the standard course of the trial, a psychologist or psychiatrist will contact participants by email and/or telephone in certain circumstances, as outlined below. After each writing session, participants will be required to rate how distressing the writing session was on a 6-point scale. If participants indicate that a writing session was at all distressing (by responding 1 or greater), then the </offsets><italic><offsets xml_i="38526" xml_f="38544" txt_i="25649" txt_f="25667">Writing for Health</offsets></italic><offsets xml_i="38553" xml_f="39077" txt_i="25667" txt_f="26191"> program will automatically display a feedback page outlining strategies to manage distress and suggest that they contact their GP if further support is needed. This page also includes the telephone number of a 24-hour telephone mental health helpline available in Australia (Lifeline). If the participant responds with a distress rating of 5 or 6 after any writing session, they will also be emailed by a psychologist, with further telephone contact based on the clinical discretion of study psychologists and psychiatrist.</offsets></p><p><offsets xml_i="39084" xml_f="39672" txt_i="26192" txt_f="26780">Participants’ depression and anxiety scores on the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7), respectively, will also be monitored. If a participant’s score is in the severe range for depression or anxiety at one-month or three-month follow-up and/or the participant indicates possible suicidal thoughts by responding 1 or greater on item 9 of the PHQ-9 (“Over the past two weeks, have you been bothered by… thoughts that you would be better off dead, or of hurting yourself in some way?”), the participant will be emailed and then telephoned by a </offsets><italic><offsets xml_i="39680" xml_f="39698" txt_i="26780" txt_f="26798">Writing for Health</offsets></italic><offsets xml_i="39707" xml_f="39857" txt_i="26798" txt_f="26948"> psychologist to assess the supports the participant is receiving, and provide contact details or referrals to appropriate services. In addition, the </offsets><italic><offsets xml_i="39865" xml_f="39883" txt_i="26948" txt_f="26966">Writing for Health</offsets></italic><offsets xml_i="39892" xml_f="40392" txt_i="26966" txt_f="27466"> program will provide automatic feedback pages at the end of the follow-up questionnaire sessions for participants who have scored in the above ranges, providing information on how to access mental health support, including the recommendation to contact their GP and the telephone number for Lifeline. Similarly, at the final three-month follow-up, the same procedure will apply to participants who score in the moderate or greater range for depression or anxiety on the PHQ-9 or GAD-7, respectively.</offsets></p></sec><sec><title><offsets xml_i="40414" xml_f="40427" txt_i="27468" txt_f="27481">Randomization</offsets></title><p><offsets xml_i="40438" xml_f="40509" txt_i="27482" txt_f="27553">Randomization to the two groups will be automatically generated by the </offsets><italic><offsets xml_i="40517" xml_f="40535" txt_i="27553" txt_f="27571">Writing for Health</offsets></italic><offsets xml_i="40544" xml_f="40680" txt_i="27571" txt_f="27707"> content management system after participants have registered with the program. Randomization is therefore concealed to the researchers.</offsets></p></sec><sec><title><offsets xml_i="40702" xml_f="40726" txt_i="27709" txt_f="27733">Primary Outcome Measures</offsets></title><sec><title><offsets xml_i="40746" xml_f="40763" txt_i="27734" txt_f="27751">Diabetes Distress</offsets></title><p><offsets xml_i="40774" xml_f="40811" txt_i="27752" txt_f="27789">The Diabetes Distress Scale (DDS17) [</offsets><xref rid="ref67" ref-type="bibr"><offsets xml_i="40845" xml_f="40847" txt_i="27789" txt_f="27791">67</offsets></xref><offsets xml_i="40854" xml_f="41372" txt_i="27791" txt_f="28309">] is a 17-item self-report measure of psychosocial stress associated with diabetes, with four reliable subscales: emotional burden (feeling overwhelmed by diabetes), physician-related distress (worries about access, trust, care), regime-related distress (concerns about diet, physical activity, medications), and interpersonal distress (not receiving understanding and appropriate support from others). Cut-off points on the DDS17 have been established for little or no distress, moderate distress, and high distress [</offsets><xref rid="ref68" ref-type="bibr"><offsets xml_i="41406" xml_f="41408" txt_i="28309" txt_f="28311">68</offsets></xref><offsets xml_i="41415" xml_f="41417" txt_i="28311" txt_f="28313">].</offsets></p></sec><sec><title><offsets xml_i="41439" xml_f="41454" txt_i="28315" txt_f="28330">Benefit-Finding</offsets></title><p><offsets xml_i="41465" xml_f="41500" txt_i="28331" txt_f="28366">The 17-item Benefit Finding Scale [</offsets><xref rid="ref51" ref-type="bibr"><offsets xml_i="41534" xml_f="41536" txt_i="28366" txt_f="28368">51</offsets></xref><offsets xml_i="41543" xml_f="41960" txt_i="28368" txt_f="28785">] was developed to investigate benefit-finding in women with early stage breast cancer. In the current study, the stem question is modified from, “Having had breast cancer has…” to, “Having had diabetes has…” Participants are asked to respond to each of the 17 perceived benefits, such as, “has lead me to be more accepting of things” and, “has brought my family closer together” on a five-point scale with labels of </offsets><italic><offsets xml_i="41968" xml_f="41978" txt_i="28785" txt_f="28795">not at all</offsets></italic><offsets xml_i="41987" xml_f="41993" txt_i="28795" txt_f="28801"> (1), </offsets><italic><offsets xml_i="42001" xml_f="42009" txt_i="28801" txt_f="28809">a little</offsets></italic><offsets xml_i="42018" xml_f="42024" txt_i="28809" txt_f="28815"> (2), </offsets><italic><offsets xml_i="42032" xml_f="42042" txt_i="28815" txt_f="28825">moderately</offsets></italic><offsets xml_i="42051" xml_f="42057" txt_i="28825" txt_f="28831"> (3), </offsets><italic><offsets xml_i="42065" xml_f="42076" txt_i="28831" txt_f="28842">quite a bit</offsets></italic><offsets xml_i="42085" xml_f="42095" txt_i="28842" txt_f="28852"> (4), and </offsets><italic><offsets xml_i="42103" xml_f="42112" txt_i="28852" txt_f="28861">extremely</offsets></italic><offsets xml_i="42121" xml_f="42349" txt_i="28861" txt_f="29089"> (5). This scale has previously been adapted for use in diabetes (with one item removed) and found to have one large factor and good internal consistency (Cronbach alpha=.89) in a population of adolescents with type 1 diabetes [</offsets><xref rid="ref55" ref-type="bibr"><offsets xml_i="42383" xml_f="42385" txt_i="29089" txt_f="29091">55</offsets></xref><offsets xml_i="42392" xml_f="42395" txt_i="29091" txt_f="29094">]. </offsets><xref ref-type="table" rid="table1"><offsets xml_i="42431" xml_f="42438" txt_i="29094" txt_f="29101">Table 1</offsets></xref><offsets xml_i="42445" xml_f="42523" txt_i="29101" txt_f="29179"> provides an overview of all measurement tools and administration time-points.</offsets></p><table-wrap id="table1" position="float"><label><offsets xml_i="42575" xml_f="42582" txt_i="29180" txt_f="29187">Table 1</offsets></label><caption><p><offsets xml_i="42602" xml_f="42653" txt_i="29187" txt_f="29238">Measurement tools and questions at each time-point.</offsets></p></caption><table frame="hsides" rules="groups" width="773" cellpadding="7" cellspacing="0" border="1"><col width="87" span="1"></col><col width="80" span="1"></col><col width="118" span="1"></col><col width="52" span="1"></col><col width="71" span="1"></col><col width="71" span="1"></col><col width="50" span="1"></col><col width="52" span="1"></col><col width="52" span="1"></col><thead><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="43187" xml_f="43201" txt_i="29241" txt_f="29255">Questionnaires</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="43234" xml_f="43242" txt_i="29256" txt_f="29264">Baseline</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="43275" xml_f="43294" txt_i="29265" txt_f="29284">Pre-writing session</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="43327" xml_f="43347" txt_i="29285" txt_f="29305">Post-writing session</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="43380" xml_f="43398" txt_i="29306" txt_f="29324">Post-final session</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="43431" xml_f="43448" txt_i="29325" txt_f="29342">1-month follow-up</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="43481" xml_f="43498" txt_i="29343" txt_f="29360">3-month follow-up</offsets></td></tr></thead><tbody><tr valign="top"><td colspan="2" rowspan="1"><bold><offsets xml_i="43574" xml_f="43586" txt_i="29361" txt_f="29373">Demographics</offsets></bold></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="43674" xml_f="43675" txt_i="29375" txt_f="29376">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold><offsets xml_i="43976" xml_f="43992" txt_i="29382" txt_f="29398">Primary outcomes</offsets></bold></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="44438" xml_f="44455" txt_i="29407" txt_f="29424">Diabetes distress</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="44488" xml_f="44511" txt_i="29425" txt_f="29448">Diabetes Distress Scale</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="44544" xml_f="44545" txt_i="29449" txt_f="29450">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="44722" xml_f="44723" txt_i="29454" txt_f="29455">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="44756" xml_f="44757" txt_i="29456" txt_f="29457">✓</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="44860" xml_f="44875" txt_i="29459" txt_f="29474">Benefit finding</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="44908" xml_f="44929" txt_i="29475" txt_f="29496">Benefit Finding Scale</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="44962" xml_f="44963" txt_i="29497" txt_f="29498">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="45140" xml_f="45141" txt_i="29502" txt_f="29503">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="45174" xml_f="45175" txt_i="29504" txt_f="29505">✓</offsets></td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold><offsets xml_i="45236" xml_f="45254" txt_i="29506" txt_f="29524">Secondary outcomes</offsets></bold></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="45700" xml_f="45710" txt_i="29533" txt_f="29543">Depression</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="45743" xml_f="45773" txt_i="29544" txt_f="29574">Patient Health Questionnaire-9</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="45806" xml_f="45807" txt_i="29575" txt_f="29576">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="45984" xml_f="45985" txt_i="29580" txt_f="29581">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="46018" xml_f="46019" txt_i="29582" txt_f="29583">✓</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="46122" xml_f="46129" txt_i="29585" txt_f="29592">Anxiety</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="46162" xml_f="46192" txt_i="29593" txt_f="29623">Generalized Anxiety Disorder-7</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="46225" xml_f="46226" txt_i="29624" txt_f="29625">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="46403" xml_f="46404" txt_i="29629" txt_f="29630">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="46437" xml_f="46438" txt_i="29631" txt_f="29632">✓</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="46541" xml_f="46559" txt_i="29634" txt_f="29652">Diabetes self-care</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="46592" xml_f="46650" txt_i="29653" txt_f="29711">Summary of Diabetes Self-Care Activities Measure (Revised)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="46683" xml_f="46684" txt_i="29712" txt_f="29713">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="46861" xml_f="46862" txt_i="29717" txt_f="29718">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="46895" xml_f="46896" txt_i="29719" txt_f="29720">✓</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="46999" xml_f="47016" txt_i="29722" txt_f="29739">Self-rated health</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="47049" xml_f="47060" txt_i="29740" txt_f="29751">Single item</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="47093" xml_f="47094" txt_i="29752" txt_f="29753">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="47271" xml_f="47272" txt_i="29757" txt_f="29758">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="47305" xml_f="47306" txt_i="29759" txt_f="29760">✓</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="47409" xml_f="47432" txt_i="29762" txt_f="29785">Health care utilization</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="47465" xml_f="47476" txt_i="29786" txt_f="29797">Single item</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="47509" xml_f="47510" txt_i="29798" txt_f="29799">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="47687" xml_f="47688" txt_i="29803" txt_f="29804">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="47721" xml_f="47722" txt_i="29805" txt_f="29806">✓</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="47825" xml_f="47853" txt_i="29808" txt_f="29836">Positive and negative affect</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="47886" xml_f="47948" txt_i="29837" txt_f="29899">International Positive and Negative Affect Schedule Short Form</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="48029" xml_f="48030" txt_i="29901" txt_f="29902">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="48063" xml_f="48064" txt_i="29903" txt_f="29904">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="48311" xml_f="48345" txt_i="29909" txt_f="29943">Experiences during writing session</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="48378" xml_f="48463" txt_i="29944" txt_f="30029">Questions assessing how personal, meaningful, and distressing the writing session was</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="48592" xml_f="48593" txt_i="30032" txt_f="30033">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="48840" xml_f="48857" txt_i="30038" txt_f="30055">User satisfaction</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="48890" xml_f="48912" txt_i="30056" txt_f="30078">Feedback Questionnaire</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><offsets xml_i="49089" xml_f="49090" txt_i="30082" txt_f="30083">✓</offsets></td><td rowspan="1" colspan="1"><break></break></td><td rowspan="1" colspan="1"><break></break></td></tr></tbody></table></table-wrap></sec></sec><sec><title><offsets xml_i="49249" xml_f="49275" txt_i="30088" txt_f="30114">Secondary Outcome Measures</offsets></title><sec><title><offsets xml_i="49295" xml_f="49314" txt_i="30115" txt_f="30134">Depression Symptoms</offsets></title><p><offsets xml_i="49325" xml_f="49336" txt_i="30135" txt_f="30146">The PHQ-9 [</offsets><xref rid="ref69" ref-type="bibr"><offsets xml_i="49370" xml_f="49372" txt_i="30146" txt_f="30148">69</offsets></xref><offsets xml_i="49379" xml_f="49629" txt_i="30148" txt_f="30398">] is a brief, widely used, reliable, and valid 9-item self-report that measures both the severity of depression over the preceding two weeks and diagnosis of depression based on criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4</offsets><sup><offsets xml_i="49634" xml_f="49636" txt_i="30398" txt_f="30400">th</offsets></sup><offsets xml_i="49642" xml_f="49745" txt_i="30400" txt_f="30503">Edition (DSM-IV). This questionnaire has established cut-off scores of 5, 10, 15, and 20, representing </offsets><italic><offsets xml_i="49753" xml_f="49757" txt_i="30503" txt_f="30507">mild</offsets></italic><offsets xml_i="49766" xml_f="49768" txt_i="30507" txt_f="30509">, </offsets><italic><offsets xml_i="49776" xml_f="49784" txt_i="30509" txt_f="30517">moderate</offsets></italic><offsets xml_i="49793" xml_f="49795" txt_i="30517" txt_f="30519">, </offsets><italic><offsets xml_i="49803" xml_f="49820" txt_i="30519" txt_f="30536">moderately severe</offsets></italic><offsets xml_i="49829" xml_f="49835" txt_i="30536" txt_f="30542">, and </offsets><italic><offsets xml_i="49843" xml_f="49849" txt_i="30542" txt_f="30548">severe</offsets></italic><offsets xml_i="49858" xml_f="50017" txt_i="30548" txt_f="30707"> depression. The total score ranges between 0 and 27, with scores equal or above 10 having a sensitivity of 88% and a specificity of 88% for major depression [</offsets><xref rid="ref69" ref-type="bibr"><offsets xml_i="50051" xml_f="50053" txt_i="30707" txt_f="30709">69</offsets></xref><offsets xml_i="50060" xml_f="50062" txt_i="30709" txt_f="30711">].</offsets></p></sec><sec><title><offsets xml_i="50084" xml_f="50100" txt_i="30713" txt_f="30729">Anxiety Symptoms</offsets></title><p><offsets xml_i="50111" xml_f="50122" txt_i="30730" txt_f="30741">The GAD-7 [</offsets><xref rid="ref70" ref-type="bibr"><offsets xml_i="50156" xml_f="50158" txt_i="30741" txt_f="30743">70</offsets></xref><offsets xml_i="50165" xml_f="50344" txt_i="30743" txt_f="30922">] is a brief, widely used, reliable, and valid 7-item self-report that measures the severity of anxiety. Scores on the GAD-7 range from 0 to 21; scores of 5, 10, and 15 represent </offsets><italic><offsets xml_i="50352" xml_f="50356" txt_i="30922" txt_f="30926">mild</offsets></italic><offsets xml_i="50365" xml_f="50367" txt_i="30926" txt_f="30928">, </offsets><italic><offsets xml_i="50375" xml_f="50384" txt_i="30928" txt_f="30937">moderate,</offsets></italic><offsets xml_i="50393" xml_f="50398" txt_i="30937" txt_f="30942"> and </offsets><italic><offsets xml_i="50406" xml_f="50412" txt_i="30942" txt_f="30948">severe</offsets></italic><offsets xml_i="50421" xml_f="50571" txt_i="30948" txt_f="31098"> anxiety symptoms. A total score of 8 on the GAD-7 has been identified as an important threshold for identifying the presence of an anxiety disorder [</offsets><xref rid="ref71" ref-type="bibr"><offsets xml_i="50605" xml_f="50607" txt_i="31098" txt_f="31100">71</offsets></xref><offsets xml_i="50614" xml_f="50616" txt_i="31100" txt_f="31102">].</offsets></p></sec><sec><title><offsets xml_i="50638" xml_f="50666" txt_i="31104" txt_f="31132">Positive and Negative Affect</offsets></title><p><offsets xml_i="50677" xml_f="50758" txt_i="31133" txt_f="31214">The International Positive and Negative Affect Schedule Short Form (I-PANAS-SF) [</offsets><xref rid="ref72" ref-type="bibr"><offsets xml_i="50792" xml_f="50794" txt_i="31214" txt_f="31216">72</offsets></xref><offsets xml_i="50801" xml_f="51143" txt_i="31216" txt_f="31558">] is a reliable and valid 10-item measure of positive and negative affect, which is comprised of 10 words that represent positive and negative affect. The correlations that this scale has with the positive and negative affect scales of the full 20-item form of the Positive and Negative Affect Schedule (PANAS) are .92 and .95, respectively [</offsets><xref rid="ref72" ref-type="bibr"><offsets xml_i="51177" xml_f="51179" txt_i="31558" txt_f="31560">72</offsets></xref><offsets xml_i="51186" xml_f="51321" txt_i="31560" txt_f="31695">]. Instructions were modified to assess state rather than trait affect, using the instructions of the 20-item PANAS-Immediate Version [</offsets><xref rid="ref73" ref-type="bibr"><offsets xml_i="51355" xml_f="51357" txt_i="31695" txt_f="31697">73</offsets></xref><offsets xml_i="51364" xml_f="51551" txt_i="31697" txt_f="31884">]. Participants will be instructed to indicate the degree of specific affect they feel, “right now, at the present moment”, on a scale of 1 to 5 (1=very slightly/not at all; 5=extremely).</offsets></p></sec><sec><title><offsets xml_i="51573" xml_f="51591" txt_i="31886" txt_f="31904">Diabetes Self-Care</offsets></title><p><offsets xml_i="51602" xml_f="51666" txt_i="31905" txt_f="31969">The Summary of Diabetes Self-Care Activities Measure (Revised) [</offsets><xref rid="ref74" ref-type="bibr"><offsets xml_i="51700" xml_f="51702" txt_i="31969" txt_f="31971">74</offsets></xref><offsets xml_i="51709" xml_f="52050" txt_i="31971" txt_f="32312">] is an 11-item self-report measure of self-care of diabetes mellitus (including diet, exercise, blood sugar testing, foot care, and smoking) that is widely used both clinically and in research. Items in the revised version were selected based on their psychometric properties, sensitivity to change, and ease of scoring and interpretation [</offsets><xref rid="ref74" ref-type="bibr"><offsets xml_i="52084" xml_f="52086" txt_i="32312" txt_f="32314">74</offsets></xref><offsets xml_i="52093" xml_f="52348" txt_i="32314" txt_f="32569">]. In a critical appraisal of 26 different measures of diabetes outcomes, the Summary of Diabetes Self-Care Activities Measure (Revised) was one of only three measures to meet all criteria of suitability, validity, reliability, and sensitivity to change [</offsets><xref rid="ref75" ref-type="bibr"><offsets xml_i="52382" xml_f="52384" txt_i="32569" txt_f="32571">75</offsets></xref><offsets xml_i="52391" xml_f="52393" txt_i="32571" txt_f="32573">].</offsets></p></sec><sec><title><offsets xml_i="52415" xml_f="52432" txt_i="32575" txt_f="32592">Self-Rated Health</offsets></title><p><offsets xml_i="52443" xml_f="52582" txt_i="32593" txt_f="32732">Self-rated health will be assessed by the question, “In general, how would you rate your health at present?” The five response options are </offsets><italic><offsets xml_i="52590" xml_f="52599" txt_i="32732" txt_f="32741">very good</offsets></italic><offsets xml_i="52608" xml_f="52610" txt_i="32741" txt_f="32743">, </offsets><italic><offsets xml_i="52618" xml_f="52622" txt_i="32743" txt_f="32747">good</offsets></italic><offsets xml_i="52631" xml_f="52633" txt_i="32747" txt_f="32749">, </offsets><italic><offsets xml_i="52641" xml_f="52645" txt_i="32749" txt_f="32753">fair</offsets></italic><offsets xml_i="52654" xml_f="52656" txt_i="32753" txt_f="32755">, </offsets><italic><offsets xml_i="52664" xml_f="52669" txt_i="32755" txt_f="32760">poor,</offsets></italic><offsets xml_i="52678" xml_f="52683" txt_i="32760" txt_f="32765"> and </offsets><italic><offsets xml_i="52691" xml_f="52700" txt_i="32765" txt_f="32774">very poor</offsets></italic><offsets xml_i="52709" xml_f="53003" txt_i="32774" txt_f="33068">. Responses to this question have previously been found to be significantly associated with blood glucose indicator hemoglobin A1c (HbA1c; with poorer self-rated health associated with higher HbA1c levels) and number of self-reported diabetes-related symptoms in patients with type 2 diabetes [</offsets><xref rid="ref76" ref-type="bibr"><offsets xml_i="53037" xml_f="53039" txt_i="33068" txt_f="33070">76</offsets></xref><offsets xml_i="53046" xml_f="53048" txt_i="33070" txt_f="33072">].</offsets></p></sec><sec><title><offsets xml_i="53070" xml_f="53093" txt_i="33074" txt_f="33097">Health Care Utilization</offsets></title><p><offsets xml_i="53104" xml_f="53371" txt_i="33098" txt_f="33365">Participants will be asked to answer the question, “In the past month, how many times have you visited a doctor or other health care professional?” This same question will be administered at three time-points: baseline, one-month follow-up, and three-month follow-up.</offsets></p></sec></sec><sec><title><offsets xml_i="53399" xml_f="53422" txt_i="33368" txt_f="33391">Additional Measurements</offsets></title><p><offsets xml_i="53433" xml_f="53652" txt_i="33392" txt_f="33611">We will collect sociodemographic information (age, gender, education, and occupation), diabetes-related information (type, duration of illness, management, and complications), and participant feedback about the program.</offsets></p><sec><title><offsets xml_i="53668" xml_f="53702" txt_i="33612" txt_f="33646">Experiences During Writing Session</offsets></title><p><offsets xml_i="53713" xml_f="54006" txt_i="33647" txt_f="33940">Immediately after each writing session, participants will be asked to rate how meaningful, personal, and distressing their writing exercise was, on a 7-point scale (0=not at all; 6=extremely). Similar questions have been used as manipulation checks in previous studies of therapeutic writing [</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="54040" xml_f="54042" txt_i="33940" txt_f="33942">42</offsets></xref><offsets xml_i="54049" xml_f="54050" txt_i="33942" txt_f="33943">,</offsets><xref rid="ref77" ref-type="bibr"><offsets xml_i="54084" xml_f="54086" txt_i="33943" txt_f="33945">77</offsets></xref><offsets xml_i="54093" xml_f="54240" txt_i="33945" txt_f="34092">]. In addition, participants in the iBFW intervention condition will be asked immediately after each writing session if they were able to identify </offsets><italic><offsets xml_i="54248" xml_f="54251" txt_i="34092" txt_f="34095">any</offsets></italic><offsets xml_i="54260" xml_f="54343" txt_i="34095" txt_f="34178"> positive thoughts or feelings about living with diabetes in their writing session.</offsets></p></sec><sec><title><offsets xml_i="54365" xml_f="54387" txt_i="34180" txt_f="34202">Feedback Questionnaire</offsets></title><p><offsets xml_i="54398" xml_f="54507" txt_i="34203" txt_f="34312">A 12-item self-report questionnaire was developed to assess participants’ experiences and perceptions of the </offsets><italic><offsets xml_i="54515" xml_f="54533" txt_i="34312" txt_f="34330">Writing for Health</offsets></italic><offsets xml_i="54542" xml_f="54731" txt_i="34330" txt_f="34519"> program. Item content was informed by self-report measures from other evaluations of Internet-based interventions. Items 1 to 6 ask participants to rate responses on a 5-point scale (from </offsets><italic><offsets xml_i="54739" xml_f="54749" txt_i="34519" txt_f="34529">not at all</offsets></italic><offsets xml_i="54758" xml_f="54762" txt_i="34529" txt_f="34533"> to </offsets><italic><offsets xml_i="54770" xml_f="54774" txt_i="34533" txt_f="34537">very</offsets></italic><offsets xml_i="54783" xml_f="54849" txt_i="34537" txt_f="34603">) regarding aspects of usability and perceived helpfulness of the </offsets><italic><offsets xml_i="54857" xml_f="54875" txt_i="34603" txt_f="34621">Writing for Health</offsets></italic><offsets xml_i="54884" xml_f="55008" txt_i="34621" txt_f="34745"> program, including how easy to use it was. Items 1 to 3 are taken from the Internet Intervention Evaluation Questionnaire [</offsets><xref rid="ref78" ref-type="bibr"><offsets xml_i="55042" xml_f="55044" txt_i="34745" txt_f="34747">78</offsets></xref><offsets xml_i="55051" xml_f="55290" txt_i="34747" txt_f="34986">]. Items 4 and 5 are modified from items previously used to assess credibility of writing interventions (asking participants to rate how logical the writing exercises seemed and how confident they would be in recommending it to a friend) [</offsets><xref rid="ref79" ref-type="bibr"><offsets xml_i="55324" xml_f="55326" txt_i="34986" txt_f="34988">79</offsets></xref><offsets xml_i="55333" xml_f="55628" txt_i="34988" txt_f="35283">]. Item 6 examined the perceived helpfulness of the writing exercises in reducing stress. Item 7 examined technical difficulties with the online program, and items 8-12 were open-ended questions examining the most helpful and least helpful aspects of the program, and any suggested improvements.</offsets></p></sec></sec></sec><sec sec-type="results"><title><offsets xml_i="55681" xml_f="55688" txt_i="35287" txt_f="35294">Results</offsets></title><sec><title><offsets xml_i="55708" xml_f="55719" txt_i="35295" txt_f="35306">Sample Size</offsets></title><p><offsets xml_i="55730" xml_f="55844" txt_i="35307" txt_f="35421">EW studies have typically had modest effect sizes, with meta-analyses reporting small effects of EW for distress (</offsets><italic><offsets xml_i="55852" xml_f="55853" txt_i="35421" txt_f="35422">r</offsets></italic><offsets xml_i="55862" xml_f="55870" txt_i="35422" txt_f="35430">=.102) [</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="55904" xml_f="55906" txt_i="35430" txt_f="35432">33</offsets></xref><offsets xml_i="55913" xml_f="55976" txt_i="35432" txt_f="35495">], and for physical health in medically ill populations (Cohen </offsets><italic><offsets xml_i="55984" xml_f="55985" txt_i="35495" txt_f="35496">d</offsets></italic><offsets xml_i="55994" xml_f="56001" txt_i="35496" txt_f="35503">=.21) [</offsets><xref rid="ref45" ref-type="bibr"><offsets xml_i="56035" xml_f="56037" txt_i="35503" txt_f="35505">45</offsets></xref><offsets xml_i="56044" xml_f="56249" txt_i="35505" txt_f="35710">]. However, of the few benefit-finding writing studies published, effect sizes appear to be greater than those for EW. Benefit-finding writing has been found to have large within-group effect sizes (Cohen </offsets><italic><offsets xml_i="56257" xml_f="56259" txt_i="35710" txt_f="35712">d=</offsets></italic><offsets xml_i="56268" xml_f="56342" txt_i="35712" txt_f="35786">.64-1.22) and small-to-moderately large between-group effect sizes (Cohen </offsets><italic><offsets xml_i="56350" xml_f="56351" txt_i="35786" txt_f="35787">d</offsets></italic><offsets xml_i="56360" xml_f="56574" txt_i="35787" txt_f="36001">=.20-0.66) for improving symptoms of complicated grief, posttraumatic stress disorder, and physical health in bereaved adults (calculated based on means and standard deviations reported in Lichtenthal et al 2010) [</offsets><xref rid="ref62" ref-type="bibr"><offsets xml_i="56608" xml_f="56610" txt_i="36001" txt_f="36003">62</offsets></xref><offsets xml_i="56617" xml_f="56708" txt_i="36003" txt_f="36094">]. Such interventions have also been found to have large between-group effect sizes (Cohen </offsets><italic><offsets xml_i="56716" xml_f="56717" txt_i="36094" txt_f="36095">d</offsets></italic><offsets xml_i="56726" xml_f="56923" txt_i="36095" txt_f="36292">=.68-2.4) for improvements in somatic symptoms and reduction in medical appointments in women with breast cancer (calculated based on means and standard deviations reported in Stanton et al 2002) [</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="56957" xml_f="56959" txt_i="36292" txt_f="36294">42</offsets></xref><offsets xml_i="56966" xml_f="56968" txt_i="36294" txt_f="36296">].</offsets></p><p><offsets xml_i="56975" xml_f="57200" txt_i="36297" txt_f="36522">A recent review of therapeutic writing called for future studies to conduct feasibility or pilot studies in new clinical populations, prior to full evaluations with sufficient statistical power to detect modest effect sizes [</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="57234" xml_f="57236" txt_i="36522" txt_f="36524">31</offsets></xref><offsets xml_i="57243" xml_f="57562" txt_i="36524" txt_f="36843">]. Given that no previous studies have examined benefit-finding writing in people with diabetes, it would be prudent to first conduct a pilot RCT to examine its feasibility and a preliminary investigation of its efficacy. Other pilot trials of therapeutic writing in clinical populations have taken a similar approach [</offsets><xref rid="ref64" ref-type="bibr"><offsets xml_i="57596" xml_f="57598" txt_i="36843" txt_f="36845">64</offsets></xref><offsets xml_i="57605" xml_f="57606" txt_i="36845" txt_f="36846">,</offsets><xref rid="ref65" ref-type="bibr"><offsets xml_i="57640" xml_f="57642" txt_i="36846" txt_f="36848">65</offsets></xref><offsets xml_i="57649" xml_f="57650" txt_i="36848" txt_f="36849">,</offsets><xref rid="ref80" ref-type="bibr"><offsets xml_i="57684" xml_f="57686" txt_i="36849" txt_f="36851">80</offsets></xref><offsets xml_i="57693" xml_f="57803" txt_i="36851" txt_f="36961">]. Thus, a very large sample required to detect a small effect size is beyond the scope of this initial study.</offsets></p><p><offsets xml_i="57810" xml_f="57989" txt_i="36962" txt_f="37141">Given that this study is partially exploratory, we therefore decided to recruit a sample size with sufficient power to detect a moderately large between-groups effect size (Cohen </offsets><italic><offsets xml_i="57997" xml_f="57998" txt_i="37141" txt_f="37142">d</offsets></italic><offsets xml_i="58007" xml_f="58072" txt_i="37142" txt_f="37207">=.7). Based on statistical power of 0.8 and probability level of </offsets><italic><offsets xml_i="58080" xml_f="58081" txt_i="37207" txt_f="37208">P</offsets></italic><offsets xml_i="58090" xml_f="58255" txt_i="37208" txt_f="37370">&lt;.05, a sample size of 26 per group (that is, 52 for each of the two groups) will be needed for one-tailed tests. Given the expected attrition rate of up to 50% [</offsets><xref rid="ref81" ref-type="bibr"><offsets xml_i="58289" xml_f="58291" txt_i="37370" txt_f="37372">81</offsets></xref><offsets xml_i="58298" xml_f="58359" txt_i="37372" txt_f="37433">], our target total sample size is therefore 104 individuals.</offsets></p></sec><sec><title><offsets xml_i="58381" xml_f="58401" txt_i="37435" txt_f="37455">Statistical Analyses</offsets></title><p><offsets xml_i="58412" xml_f="58983" txt_i="37456" txt_f="38027">Statistical analyses will be conducted using SPSS 22 software. Group differences in demographic data, diabetes-related variables, and baseline measures will be analyzed using one-way analysis of variance (continuous variables) and chi-square tests (categorical variables). Similar analyses will be conducted to compare participants who do (nondropouts) and do not (dropouts) complete all questionnaires at each of the time-points, to explore possible biases in study attrition. Analyses will be conducted to validate the writing intervention instructions in several ways:</offsets></p><p><offsets xml_i="58990" xml_f="59087" txt_i="38028" txt_f="38125">To examine immediate emotional responses to the writing interventions, scores on the I-PANAS-SF [</offsets><xref rid="ref72" ref-type="bibr"><offsets xml_i="59121" xml_f="59123" txt_i="38125" txt_f="38127">72</offsets></xref><offsets xml_i="59130" xml_f="59513" txt_i="38127" txt_f="38510">] administered immediately before and after each writing session will be analyzed using a 2 (group) x 3 (session) x 2 (positive affect and negative affect) repeated measures multivariate analysis of variance. This test will be used to investigate the hypothesis that the benefit-finding group will have greater increases in positive affect postwriting, relative to the control group.</offsets></p><p><offsets xml_i="59520" xml_f="59650" txt_i="38511" txt_f="38641">The content of the written scripts in both groups will be assessed using the Linguistic Inquiry Word Count 2007 software program [</offsets><xref rid="ref82" ref-type="bibr"><offsets xml_i="59684" xml_f="59686" txt_i="38641" txt_f="38643">82</offsets></xref><offsets xml_i="59693" xml_f="60144" txt_i="38643" txt_f="39094">], to examine differences in positive emotion words and cognitive insight words. This validated method provides a content analysis of the language used in the scripts, and quantifies the number of words used from specific categories (eg, emotions, cognitive processes). This approach will be used to investigate the hypothesis that the benefit-finding group will use more positive emotion words and more cognitive insight words than the control group.</offsets></p><p><offsets xml_i="60151" xml_f="60577" txt_i="39095" txt_f="39521">Scores on the feedback questionnaire, a measure developed to assess user satisfaction and perceived usefulness of the intervention, will be compared between the two groups using analyses of variances. These tests will be used to examine the hypothesis that the participants in the benefit-finding group will have higher levels of user satisfaction and perceived helpfulness of the writing tasks, relative to the control group.</offsets></p><p><offsets xml_i="60584" xml_f="61189" txt_i="39522" txt_f="40127">Outcome data at the one-month and three-month follow-up time-points will be analyzed on an intention-to-treat basis using linear mixed modelling, with time-points as a within-group factor and intervention as a between-group factor. The interaction of time and study condition will be examined in each analysis, as a significant interaction will indicate a group difference in the pattern of change over time in the outcome of interest. Significant interactions will be explored using Bonferroni adjusted comparisons of the two groups at one-month and three-month follow-ups. All effects will be tested at </offsets><italic><offsets xml_i="61197" xml_f="61198" txt_i="40127" txt_f="40128">P</offsets></italic><offsets xml_i="61207" xml_f="61253" txt_i="40128" txt_f="40171">&lt;.05. Within-group and between-group Cohen </offsets><italic><offsets xml_i="61261" xml_f="61262" txt_i="40171" txt_f="40172">d</offsets></italic><offsets xml_i="61271" xml_f="61304" txt_i="40172" txt_f="40205"> effect sizes will be calculated.</offsets></p></sec><sec><title><offsets xml_i="61326" xml_f="61338" txt_i="40207" txt_f="40219">Trial Status</offsets></title><p><offsets xml_i="61349" xml_f="61489" txt_i="40220" txt_f="40360">The trial is currently in the data collection phase. Recruitment to the study commenced in February 2015. Results are expected by July 2017.</offsets></p></sec></sec><sec sec-type="discussion"><title><offsets xml_i="61539" xml_f="61549" txt_i="40363" txt_f="40373">Discussion</offsets></title><p><offsets xml_i="61560" xml_f="62250" txt_i="40374" txt_f="41064">This study will be the first to examine benefit-finding writing for adults with type 1 or type 2 diabetes. The feasibility and efficacy of this brief intervention will be evaluated in a two-arm RCT, with a three-month follow-up period, in which iBFW for diabetes is compared to an active control condition (use-of-time writing). The participants in this study will be adults with type 1 or type 2 diabetes who may be experiencing diabetes distress and/or mild symptoms of depression or anxiety. Participants with both type 1 and type 2 diabetes will be included in this study, as perceived benefits of living with diabetes have previously been reported by both people with type 1 diabetes [</offsets><xref rid="ref55" ref-type="bibr"><offsets xml_i="62284" xml_f="62286" txt_i="41064" txt_f="41066">55</offsets></xref><offsets xml_i="62293" xml_f="62316" txt_i="41066" txt_f="41089">] and type 2 diabetes [</offsets><xref rid="ref83" ref-type="bibr"><offsets xml_i="62350" xml_f="62352" txt_i="41089" txt_f="41091">83</offsets></xref><offsets xml_i="62359" xml_f="62847" txt_i="41091" txt_f="41579">]. Outcomes assessed will include multiple psychological and diabetes-specific variables, including the primary outcomes of diabetes distress and benefit-finding for diabetes, and secondary outcomes of symptoms of depression and anxiety, diabetes self-care, perceived health, and health care utilization. Furthermore, we will investigate validation of the intervention by examining immediate emotional responses to the writing tasks and conduct linguistic analyses of the writing scripts.</offsets></p><p><offsets xml_i="62854" xml_f="63244" txt_i="41580" txt_f="41970">Results from this trial will contribute to the growing body of knowledge about a more recent form of therapeutic writing, known as benefit-finding writing. The limited research on benefit-finding writing to date suggests that it may have the same health benefits of the more commonly researched EW, but with the advantage of increased positive affect immediately following the intervention.</offsets></p><p><offsets xml_i="63251" xml_f="63883" txt_i="41971" txt_f="42603">Limitations to this study include the brevity of the follow-up period (three months) and the reliance on self-reported data. Physiological data, such as HbA1c or other indicators of blood glucose level, are not included in this study. The included outcome of health utilization has limitations itself, as participants may not visit health professionals frequently enough for any changes to be detected in the follow-up period of three months. Furthermore, it is unclear as to whether decreased health care utilization is a positive outcome, given that going to an appropriate health professional when a need exists is a good thing [</offsets><xref rid="ref84" ref-type="bibr"><offsets xml_i="63917" xml_f="63919" txt_i="42603" txt_f="42605">84</offsets></xref><offsets xml_i="63926" xml_f="64182" txt_i="42605" txt_f="42861">]. Nevertheless, we have included assessment of this outcome as any changes in health care utilization in people with diabetes would be of interest, and previous trials of EW and benefit-finding writing have reported reductions in health care utilization [</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="64216" xml_f="64218" txt_i="42861" txt_f="42863">42</offsets></xref><offsets xml_i="64225" xml_f="64226" txt_i="42863" txt_f="42864">,</offsets><xref rid="ref84" ref-type="bibr"><offsets xml_i="64260" xml_f="64262" txt_i="42864" txt_f="42866">84</offsets></xref><offsets xml_i="64269" xml_f="64271" txt_i="42866" txt_f="42868">].</offsets></p><p><offsets xml_i="64278" xml_f="64778" txt_i="42869" txt_f="43369">Similar to many RCTs, the generalizability of our results is restricted by the exclusion criteria. For example, adults with diabetes currently experiencing depression of moderate or greater severity will be excluded from this trial; hence the results will not be able to be generalized to people with diabetes who are currently depressed. Furthermore, the sample size (N=104) will enable the detection of a moderately large effect size, in line with some previous studies of benefit-finding writing [</offsets><xref rid="ref42" ref-type="bibr"><offsets xml_i="64812" xml_f="64814" txt_i="43369" txt_f="43371">42</offsets></xref><offsets xml_i="64821" xml_f="65016" txt_i="43371" txt_f="43566">], but will not allow for the detection of small effect sizes reported in meta-analyses of writing interventions. However, as recommended in a recent comprehensive review of therapeutic writing [</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="65050" xml_f="65052" txt_i="43566" txt_f="43568">31</offsets></xref></p><p><offsets xml_i="65066" xml_f="65469" txt_i="43569" txt_f="43972">If the iBFW is found to be helpful for people with type 1 or type 2 diabetes, this intervention will offer the potential to be a low-cost, easily accessible public health intervention to improve the well-being of large numbers of diabetic patients with lower-level psychological needs. Furthermore, benefit-finding writing may also have the potential to assist other populations with chronic conditions.</offsets></p></sec></body><back><ack><p>We would like to acknowledge the support of Faces in the Street: Urban Mental Health Research Institute, St. Vincent’s Hospital Australia, and the contribution of Ms. Therese Fletcher in monitoring the trial. This research is being conducted by JC as part of her PhD candidature with the School of Psychiatry, Faculty of Medicine at the University of New South Wales. JC’s PhD is supported by an Australian Postgraduate Award scholarship.</p></ack><fn-group><fn fn-type="con"><p>Authors' Contributions: JC, KW, and JP conceived of the study and initiated the study design and protocol. JC managed the trail implementation and drafted this paper. LR assisted with implementation of the trail and contributed to this paper. All authors approved the final manuscript.</p></fn><fn fn-type="COI-statement"><p>Conflicts of Interest: None declared.</p></fn></fn-group><app-group><app id="app1"><title>Multimedia Appendix 1</title><p>Instructions for Internet-based benefit-finding writing (iBFW) for diabetes.</p><fig id="d35e1495" position="anchor"><media xlink:href="resprot_v6i3e42_app1.pdf"></media></fig></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">DDS17</term><def><p>Diabetes Distress Scale</p></def></def-item><def-item><term id="abb2">EW</term><def><p>expressive writing</p></def></def-item><def-item><term id="abb3">GAD-7</term><def><p>Generalized Anxiety Disorder-7</p></def></def-item><def-item><term id="abb4">HbA1c</term><def><p>hemoglobin A1c</p></def></def-item><def-item><term id="abb5">iBFW</term><def><p>Internet-based benefit-finding writing</p></def></def-item><def-item><term id="abb6">I-PANAS-SF</term><def><p>International Positive and Negative Affect Schedule Short Form</p></def></def-item><def-item><term id="abb7">PANAS</term><def><p>Positive and Negative Affect Schedule</p></def></def-item><def-item><term id="abb8">PHQ-9</term><def><p>Patient Health Questionnaire-9</p></def></def-item><def-item><term id="abb9">RCT</term><def><p>randomized controlled trial</p></def></def-item></def-list></glossary><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>CJ</given-names></name><name><surname>Vos</surname><given-names>T</given-names></name><name><surname>Lozano</surname><given-names>R</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name><name><surname>Flaxman</surname><given-names>AD</given-names></name><name><surname>Michaud</surname><given-names>C</given-names></name><name><surname>Ezzati</surname><given-names>M</given-names></name><name><surname>Shibuya</surname><given-names>K</given-names></name><name><surname>Salomon</surname><given-names>JA</given-names></name><name><surname>Abdalla</surname><given-names>S</given-names></name><name><surname>Aboyans</surname><given-names>V</given-names></name><name><surname>Abraham</surname><given-names>J</given-names></name><name><surname>Ackerman</surname><given-names>I</given-names></name><name><surname>Aggarwal</surname><given-names>R</given-names></name><name><surname>Ahn</surname><given-names>SY</given-names></name><name><surname>Ali</surname><given-names>MK</given-names></name><name><surname>Alvarado</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>HR</given-names></name><name><surname>Anderson</surname><given-names>LM</given-names></name><name><surname>Andrews</surname><given-names>KG</given-names></name><name><surname>Atkinson</surname><given-names>C</given-names></name><name><surname>Baddour</surname><given-names>LM</given-names></name><name><surname>Bahalim</surname><given-names>AN</given-names></name><name><surname>Barker-Collo</surname><given-names>S</given-names></name><name><surname>Barrero</surname><given-names>LH</given-names></name><name><surname>Bartels</surname><given-names>DH</given-names></name><name><surname>Basáñez</surname><given-names>MG</given-names></name><name><surname>Baxter</surname><given-names>A</given-names></name><name><surname>Bell</surname><given-names>ML</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Bennett</surname><given-names>D</given-names></name><name><surname>Bernabé</surname><given-names>E</given-names></name><name><surname>Bhalla</surname><given-names>K</given-names></name><name><surname>Bhandari</surname><given-names>B</given-names></name><name><surname>Bikbov</surname><given-names>B</given-names></name><name><surname>Bin</surname><given-names>AA</given-names></name><name><surname>Birbeck</surname><given-names>G</given-names></name><name><surname>Black</surname><given-names>JA</given-names></name><name><surname>Blencowe</surname><given-names>H</given-names></name><name><surname>Blore</surname><given-names>JD</given-names></name><name><surname>Blyth</surname><given-names>F</given-names></name><name><surname>Bolliger</surname><given-names>I</given-names></name><name><surname>Bonaventure</surname><given-names>A</given-names></name><name><surname>Boufous</surname><given-names>S</given-names></name><name><surname>Bourne</surname><given-names>R</given-names></name><name><surname>Boussinesq</surname><given-names>M</given-names></name><name><surname>Braithwaite</surname><given-names>T</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><name><surname>Bridgett</surname><given-names>L</given-names></name><name><surname>Brooker</surname><given-names>S</given-names></name><name><surname>Brooks</surname><given-names>P</given-names></name><name><surname>Brugha</surname><given-names>TS</given-names></name><name><surname>Bryan-Hancock</surname><given-names>C</given-names></name><name><surname>Bucello</surname><given-names>C</given-names></name><name><surname>Buchbinder</surname><given-names>R</given-names></name><name><surname>Buckle</surname><given-names>G</given-names></name><name><surname>Budke</surname><given-names>CM</given-names></name><name><surname>Burch</surname><given-names>M</given-names></name><name><surname>Burney</surname><given-names>P</given-names></name><name><surname>Burstein</surname><given-names>R</given-names></name><name><surname>Calabria</surname><given-names>B</given-names></name><name><surname>Campbell</surname><given-names>B</given-names></name><name><surname>Canter</surname><given-names>CE</given-names></name><name><surname>Carabin</surname><given-names>H</given-names></name><name><surname>Carapetis</surname><given-names>J</given-names></name><name><surname>Carmona</surname><given-names>L</given-names></name><name><surname>Cella</surname><given-names>C</given-names></name><name><surname>Charlson</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>AT</given-names></name><name><surname>Chou</surname><given-names>D</given-names></name><name><surname>Chugh</surname><given-names>SS</given-names></name><name><surname>Coffeng</surname><given-names>LE</given-names></name><name><surname>Colan</surname><given-names>SD</given-names></name><name><surname>Colquhoun</surname><given-names>S</given-names></name><name><surname>Colson</surname><given-names>KE</given-names></name><name><surname>Condon</surname><given-names>J</given-names></name><name><surname>Connor</surname><given-names>MD</given-names></name><name><surname>Cooper</surname><given-names>LT</given-names></name><name><surname>Corriere</surname><given-names>M</given-names></name><name><surname>Cortinovis</surname><given-names>M</given-names></name><name><surname>de Vaccaro</surname><given-names>KC</given-names></name><name><surname>Couser</surname><given-names>W</given-names></name><name><surname>Cowie</surname><given-names>BC</given-names></name><name><surname>Criqui</surname><given-names>MH</given-names></name><name><surname>Cross</surname><given-names>M</given-names></name><name><surname>Dabhadkar</surname><given-names>KC</given-names></name><name><surname>Dahiya</surname><given-names>M</given-names></name><name><surname>Dahodwala</surname><given-names>N</given-names></name><name><surname>Damsere-Derry</surname><given-names>J</given-names></name><name><surname>Danaei</surname><given-names>G</given-names></name><name><surname>Davis</surname><given-names>A</given-names></name><name><surname>De Leo</surname><given-names>D</given-names></name><name><surname>Degenhardt</surname><given-names>L</given-names></name><name><surname>Dellavalle</surname><given-names>R</given-names></name><name><surname>Delossantos</surname><given-names>A</given-names></name><name><surname>Denenberg</surname><given-names>J</given-names></name><name><surname>Derrett</surname><given-names>S</given-names></name><name><surname>Des Jarlais</surname><given-names>DC</given-names></name><name><surname>Dharmaratne</surname><given-names>SD</given-names></name><name><surname>Dherani</surname><given-names>M</given-names></name><name><surname>Diaz-Torne</surname><given-names>C</given-names></name><name><surname>Dolk</surname><given-names>H</given-names></name><name><surname>Dorsey</surname><given-names>ER</given-names></name><name><surname>Driscoll</surname><given-names>T</given-names></name><name><surname>Duber</surname><given-names>H</given-names></name><name><surname>Ebel</surname><given-names>B</given-names></name><name><surname>Edmond</surname><given-names>K</given-names></name><name><surname>Elbaz</surname><given-names>A</given-names></name><name><surname>Ali</surname><given-names>SE</given-names></name><name><surname>Erskine</surname><given-names>H</given-names></name><name><surname>Erwin</surname><given-names>PJ</given-names></name><name><surname>Espindola</surname><given-names>P</given-names></name><name><surname>Ewoigbokhan</surname><given-names>SE</given-names></name><name><surname>Farzadfar</surname><given-names>F</given-names></name><name><surname>Feigin</surname><given-names>V</given-names></name><name><surname>Felson</surname><given-names>DT</given-names></name><name><surname>Ferrari</surname><given-names>A</given-names></name><name><surname>Ferri</surname><given-names>CP</given-names></name><name><surname>Fèvre</surname><given-names>EM</given-names></name><name><surname>Finucane</surname><given-names>MM</given-names></name><name><surname>Flaxman</surname><given-names>S</given-names></name><name><surname>Flood</surname><given-names>L</given-names></name><name><surname>Foreman</surname><given-names>K</given-names></name><name><surname>Forouzanfar</surname><given-names>MH</given-names></name><name><surname>Fowkes</surname><given-names>FG</given-names></name><name><surname>Fransen</surname><given-names>M</given-names></name><name><surname>Freeman</surname><given-names>MK</given-names></name><name><surname>Gabbe</surname><given-names>BJ</given-names></name><name><surname>Gabriel</surname><given-names>SE</given-names></name><name><surname>Gakidou</surname><given-names>E</given-names></name><name><surname>Ganatra</surname><given-names>HA</given-names></name><name><surname>Garcia</surname><given-names>B</given-names></name><name><surname>Gaspari</surname><given-names>F</given-names></name><name><surname>Gillum</surname><given-names>RF</given-names></name><name><surname>Gmel</surname><given-names>G</given-names></name><name><surname>Gonzalez-Medina</surname><given-names>D</given-names></name><name><surname>Gosselin</surname><given-names>R</given-names></name><name><surname>Grainger</surname><given-names>R</given-names></name><name><surname>Grant</surname><given-names>B</given-names></name><name><surname>Groeger</surname><given-names>J</given-names></name><name><surname>Guillemin</surname><given-names>F</given-names></name><name><surname>Gunnell</surname><given-names>D</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Haagsma</surname><given-names>J</given-names></name><name><surname>Hagan</surname><given-names>H</given-names></name><name><surname>Halasa</surname><given-names>YA</given-names></name><name><surname>Hall</surname><given-names>W</given-names></name><name><surname>Haring</surname><given-names>D</given-names></name><name><surname>Haro</surname><given-names>JM</given-names></name><name><surname>Harrison</surname><given-names>JE</given-names></name><name><surname>Havmoeller</surname><given-names>R</given-names></name><name><surname>Hay</surname><given-names>RJ</given-names></name><name><surname>Higashi</surname><given-names>H</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Hoen</surname><given-names>B</given-names></name><name><surname>Hoffman</surname><given-names>H</given-names></name><name><surname>Hotez</surname><given-names>PJ</given-names></name><name><surname>Hoy</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>JJ</given-names></name><name><surname>Ibeanusi</surname><given-names>SE</given-names></name><name><surname>Jacobsen</surname><given-names>KH</given-names></name><name><surname>James</surname><given-names>SL</given-names></name><name><surname>Jarvis</surname><given-names>D</given-names></name><name><surname>Jasrasaria</surname><given-names>R</given-names></name><name><surname>Jayaraman</surname><given-names>S</given-names></name><name><surname>Johns</surname><given-names>N</given-names></name><name><surname>Jonas</surname><given-names>JB</given-names></name><name><surname>Karthikeyan</surname><given-names>G</given-names></name><name><surname>Kassebaum</surname><given-names>N</given-names></name><name><surname>Kawakami</surname><given-names>N</given-names></name><name><surname>Keren</surname><given-names>A</given-names></name><name><surname>Khoo</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>CH</given-names></name><name><surname>Knowlton</surname><given-names>LM</given-names></name><name><surname>Kobusingye</surname><given-names>O</given-names></name><name><surname>Koranteng</surname><given-names>A</given-names></name><name><surname>Krishnamurthi</surname><given-names>R</given-names></name><name><surname>Laden</surname><given-names>F</given-names></name><name><surname>Lalloo</surname><given-names>R</given-names></name><name><surname>Laslett</surname><given-names>LL</given-names></name><name><surname>Lathlean</surname><given-names>T</given-names></name><name><surname>Leasher</surname><given-names>JL</given-names></name><name><surname>Lee</surname><given-names>YY</given-names></name><name><surname>Leigh</surname><given-names>J</given-names></name><name><surname>Levinson</surname><given-names>D</given-names></name><name><surname>Lim</surname><given-names>SS</given-names></name><name><surname>Limb</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>JK</given-names></name><name><surname>Lipnick</surname><given-names>M</given-names></name><name><surname>Lipshultz</surname><given-names>SE</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Loane</surname><given-names>M</given-names></name><name><surname>Ohno</surname><given-names>SL</given-names></name><name><surname>Lyons</surname><given-names>R</given-names></name><name><surname>Mabweijano</surname><given-names>J</given-names></name><name><surname>MacIntyre</surname><given-names>MF</given-names></name><name><surname>Malekzadeh</surname><given-names>R</given-names></name><name><surname>Mallinger</surname><given-names>L</given-names></name><name><surname>Manivannan</surname><given-names>S</given-names></name><name><surname>Marcenes</surname><given-names>W</given-names></name><name><surname>March</surname><given-names>L</given-names></name><name><surname>Margolis</surname><given-names>DJ</given-names></name><name><surname>Marks</surname><given-names>GB</given-names></name><name><surname>Marks</surname><given-names>R</given-names></name><name><surname>Matsumori</surname><given-names>A</given-names></name><name><surname>Matzopoulos</surname><given-names>R</given-names></name><name><surname>Mayosi</surname><given-names>BM</given-names></name><name><surname>McAnulty</surname><given-names>JH</given-names></name><name><surname>McDermott</surname><given-names>MM</given-names></name><name><surname>McGill</surname><given-names>N</given-names></name><name><surname>McGrath</surname><given-names>J</given-names></name><name><surname>Medina-Mora</surname><given-names>ME</given-names></name><name><surname>Meltzer</surname><given-names>M</given-names></name><name><surname>Mensah</surname><given-names>GA</given-names></name><name><surname>Merriman</surname><given-names>TR</given-names></name><name><surname>Meyer</surname><given-names>A</given-names></name><name><surname>Miglioli</surname><given-names>V</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>TR</given-names></name><name><surname>Mitchell</surname><given-names>PB</given-names></name><name><surname>Mock</surname><given-names>C</given-names></name><name><surname>Mocumbi</surname><given-names>AO</given-names></name><name><surname>Moffitt</surname><given-names>TE</given-names></name><name><surname>Mokdad</surname><given-names>AA</given-names></name><name><surname>Monasta</surname><given-names>L</given-names></name><name><surname>Montico</surname><given-names>M</given-names></name><name><surname>Moradi-Lakeh</surname><given-names>M</given-names></name><name><surname>Moran</surname><given-names>A</given-names></name><name><surname>Morawska</surname><given-names>L</given-names></name><name><surname>Mori</surname><given-names>R</given-names></name><name><surname>Murdoch</surname><given-names>ME</given-names></name><name><surname>Mwaniki</surname><given-names>MK</given-names></name><name><surname>Naidoo</surname><given-names>K</given-names></name><name><surname>Nair</surname><given-names>MN</given-names></name><name><surname>Naldi</surname><given-names>L</given-names></name><name><surname>Narayan</surname><given-names>KM</given-names></name><name><surname>Nelson</surname><given-names>PK</given-names></name><name><surname>Nelson</surname><given-names>RG</given-names></name><name><surname>Nevitt</surname><given-names>MC</given-names></name><name><surname>Newton</surname><given-names>CR</given-names></name><name><surname>Nolte</surname><given-names>S</given-names></name><name><surname>Norman</surname><given-names>P</given-names></name><name><surname>Norman</surname><given-names>R</given-names></name><name><surname>O'Donnell</surname><given-names>M</given-names></name><name><surname>O'Hanlon</surname><given-names>S</given-names></name><name><surname>Olives</surname><given-names>C</given-names></name><name><surname>Omer</surname><given-names>SB</given-names></name><name><surname>Ortblad</surname><given-names>K</given-names></name><name><surname>Osborne</surname><given-names>R</given-names></name><name><surname>Ozgediz</surname><given-names>D</given-names></name><name><surname>Page</surname><given-names>A</given-names></name><name><surname>Pahari</surname><given-names>B</given-names></name><name><surname>Pandian</surname><given-names>JD</given-names></name><name><surname>Rivero</surname><given-names>AP</given-names></name><name><surname>Patten</surname><given-names>SB</given-names></name><name><surname>Pearce</surname><given-names>N</given-names></name><name><surname>Padilla</surname><given-names>RP</given-names></name><name><surname>Perez-Ruiz</surname><given-names>F</given-names></name><name><surname>Perico</surname><given-names>N</given-names></name><name><surname>Pesudovs</surname><given-names>K</given-names></name><name><surname>Phillips</surname><given-names>D</given-names></name><name><surname>Phillips</surname><given-names>MR</given-names></name><name><surname>Pierce</surname><given-names>K</given-names></name><name><surname>Pion</surname><given-names>S</given-names></name><name><surname>Polanczyk</surname><given-names>GV</given-names></name><name><surname>Polinder</surname><given-names>S</given-names></name><name><surname>Pope</surname><given-names>CA</given-names></name><name><surname>Popova</surname><given-names>S</given-names></name><name><surname>Porrini</surname><given-names>E</given-names></name><name><surname>Pourmalek</surname><given-names>F</given-names></name><name><surname>Prince</surname><given-names>M</given-names></name><name><surname>Pullan</surname><given-names>RL</given-names></name><name><surname>Ramaiah</surname><given-names>KD</given-names></name><name><surname>Ranganathan</surname><given-names>D</given-names></name><name><surname>Razavi</surname><given-names>H</given-names></name><name><surname>Regan</surname><given-names>M</given-names></name><name><surname>Rehm</surname><given-names>JT</given-names></name><name><surname>Rein</surname><given-names>DB</given-names></name><name><surname>Remuzzi</surname><given-names>G</given-names></name><name><surname>Richardson</surname><given-names>K</given-names></name><name><surname>Rivara</surname><given-names>FP</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Robinson</surname><given-names>C</given-names></name><name><surname>De Leòn</surname><given-names>FR</given-names></name><name><surname>Ronfani</surname><given-names>L</given-names></name><name><surname>Room</surname><given-names>R</given-names></name><name><surname>Rosenfeld</surname><given-names>LC</given-names></name><name><surname>Rushton</surname><given-names>L</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Sampson</surname><given-names>U</given-names></name><name><surname>Sanchez-Riera</surname><given-names>L</given-names></name><name><surname>Sanman</surname><given-names>E</given-names></name><name><surname>Schwebel</surname><given-names>DC</given-names></name><name><surname>Scott</surname><given-names>JG</given-names></name><name><surname>Segui-Gomez</surname><given-names>M</given-names></name><name><surname>Shahraz</surname><given-names>S</given-names></name><name><surname>Shepard</surname><given-names>DS</given-names></name><name><surname>Shin</surname><given-names>H</given-names></name><name><surname>Shivakoti</surname><given-names>R</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>GM</given-names></name><name><surname>Singh</surname><given-names>JA</given-names></name><name><surname>Singleton</surname><given-names>J</given-names></name><name><surname>Sleet</surname><given-names>DA</given-names></name><name><surname>Sliwa</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>JL</given-names></name><name><surname>Stapelberg</surname><given-names>NJ</given-names></name><name><surname>Steer</surname><given-names>A</given-names></name><name><surname>Steiner</surname><given-names>T</given-names></name><name><surname>Stolk</surname><given-names>WA</given-names></name><name><surname>Stovner</surname><given-names>LJ</given-names></name><name><surname>Sudfeld</surname><given-names>C</given-names></name><name><surname>Syed</surname><given-names>S</given-names></name><name><surname>Tamburlini</surname><given-names>G</given-names></name><name><surname>Tavakkoli</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>HR</given-names></name><name><surname>Taylor</surname><given-names>JA</given-names></name><name><surname>Taylor</surname><given-names>WJ</given-names></name><name><surname>Thomas</surname><given-names>B</given-names></name><name><surname>Thomson</surname><given-names>WM</given-names></name><name><surname>Thurston</surname><given-names>GD</given-names></name><name><surname>Tleyjeh</surname><given-names>IM</given-names></name><name><surname>Tonelli</surname><given-names>M</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Truelsen</surname><given-names>T</given-names></name><name><surname>Tsilimbaris</surname><given-names>MK</given-names></name><name><surname>Ubeda</surname><given-names>C</given-names></name><name><surname>Undurraga</surname><given-names>EA</given-names></name><name><surname>van der Werf</surname><given-names>MJ</given-names></name><name><surname>van OS</surname><given-names>J</given-names></name><name><surname>Vavilala</surname><given-names>MS</given-names></name><name><surname>Venketasubramanian</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Watt</surname><given-names>K</given-names></name><name><surname>Weatherall</surname><given-names>DJ</given-names></name><name><surname>Weinstock</surname><given-names>MA</given-names></name><name><surname>Weintraub</surname><given-names>R</given-names></name><name><surname>Weisskopf</surname><given-names>MG</given-names></name><name><surname>Weissman</surname><given-names>MM</given-names></name><name><surname>White</surname><given-names>RA</given-names></name><name><surname>Whiteford</surname><given-names>H</given-names></name><name><surname>Wiebe</surname><given-names>N</given-names></name><name><surname>Wiersma</surname><given-names>ST</given-names></name><name><surname>Wilkinson</surname><given-names>JD</given-names></name><name><surname>Williams</surname><given-names>HC</given-names></name><name><surname>Williams</surname><given-names>SR</given-names></name><name><surname>Witt</surname><given-names>E</given-names></name><name><surname>Wolfe</surname><given-names>F</given-names></name><name><surname>Woolf</surname><given-names>AD</given-names></name><name><surname>Wulf</surname><given-names>S</given-names></name><name><surname>Yeh</surname><given-names>P</given-names></name><name><surname>Zaidi</surname><given-names>AK</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Zonies</surname><given-names>D</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name><name><surname>AlMazroa</surname><given-names>MA</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name></person-group><article-title>Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010</article-title><source>Lancet</source><year>2012</year><month>12</month><day>15</day><volume>380</volume><issue>9859</issue><fpage>2197</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)61689-4</pub-id><pub-id pub-id-type="medline">23245608</pub-id><pub-id pub-id-type="pmid">23245608</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>NCD Risk Factor Collaboration (NCD-RisC)</collab></person-group><article-title>Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants</article-title><source>Lancet</source><year>2016</year><month>4</month><day>09</day><volume>387</volume><issue>10027</issue><fpage>1513</fpage><lpage>30</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(16)00618-8"></ext-link></comment><pub-id pub-id-type="doi">10.1016/S0140-6736(16)00618-8</pub-id><pub-id pub-id-type="medline">27061677</pub-id><pub-id pub-id-type="pmid">27061677</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RJ</given-names></name><name><surname>Freedland</surname><given-names>KE</given-names></name><name><surname>Clouse</surname><given-names>RE</given-names></name><name><surname>Lustman</surname><given-names>PJ</given-names></name></person-group><article-title>The prevalence of comorbid depression in adults with diabetes: a meta-analysis</article-title><source>Diabetes Care</source><year>2001</year><month>6</month><volume>24</volume><issue>6</issue><fpage>1069</fpage><lpage>78</lpage><pub-id pub-id-type="medline">11375373</pub-id><pub-id pub-id-type="pmid">11375373</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grigsby</surname><given-names>AB</given-names></name><name><surname>Anderson</surname><given-names>RJ</given-names></name><name><surname>Freedland</surname><given-names>KE</given-names></name><name><surname>Clouse</surname><given-names>RE</given-names></name><name><surname>Lustman</surname><given-names>PJ</given-names></name></person-group><article-title>Prevalence of anxiety in adults with diabetes: a systematic review</article-title><source>J Psychosom Res</source><year>2002</year><month>12</month><volume>53</volume><issue>6</issue><fpage>1053</fpage><lpage>60</lpage><pub-id pub-id-type="medline">12479986</pub-id><pub-id pub-id-type="pmid">12479986</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>T</given-names></name><name><surname>Lloyd</surname><given-names>CE</given-names></name></person-group><article-title>Epidemiology of depression and diabetes: a systematic review</article-title><source>J Affect Disord</source><year>2012</year><month>10</month><volume>142 Suppl</volume><fpage>S8</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/S0165-0327(12)70004-6</pub-id><pub-id pub-id-type="medline">23062861</pub-id><pub-id pub-id-type="pmid">23062861</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Anastasiades</surname><given-names>M</given-names></name><name><surname>Gupton</surname><given-names>O</given-names></name><name><surname>Fritz</surname><given-names>Y</given-names></name><name><surname>Calzada</surname><given-names>P</given-names></name><name><surname>Stillman</surname><given-names>MA</given-names></name></person-group><source>Mental Health in Family Medicine, 12 (3)</source><year>2016</year><date-in-citation>2016-12-11</date-in-citation><comment>Diabetes, depression and nonadherencexploring hopelessness as a mediating factor: a preliminary study
<ext-link ext-link-type="uri" xlink:href="http://www.mhfmjournal.com/open-access/diabetes-depression-and-nonadherence-exploring-hopelessness-as-a-meditating-factor-a-preliminary-study.pdf">http://www.mhfmjournal.com/open-access/diabetes-depression-and-nonadherence-exploring-hopelessness-as-a-meditating-factor-a-preliminary-study.pdf</ext-link><ext-link ext-link-type="webcite" xlink:href="6mfpMpdaY"></ext-link></comment></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>JS</given-names></name><name><surname>Safren</surname><given-names>SA</given-names></name><name><surname>Delahanty</surname><given-names>LM</given-names></name><name><surname>Cagliero</surname><given-names>E</given-names></name><name><surname>Wexler</surname><given-names>DJ</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Grant</surname><given-names>RW</given-names></name></person-group><article-title>Symptoms of depression prospectively predict poorer self-care in patients with type 2 diabetes</article-title><source>Diabet Med</source><year>2008</year><month>9</month><volume>25</volume><issue>9</issue><fpage>1102</fpage><lpage>7</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/19183315"></ext-link></comment><pub-id pub-id-type="doi">10.1111/j.1464-5491.2008.02535.x</pub-id><pub-id pub-id-type="medline">19183315</pub-id><pub-id pub-id-type="pmid">19183315</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egede</surname><given-names>LE</given-names></name><name><surname>Nietert</surname><given-names>PJ</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name></person-group><article-title>Depression and all-cause and coronary heart disease mortality among adults with and without diabetes</article-title><source>Diabetes Care</source><year>2005</year><month>6</month><volume>28</volume><issue>6</issue><fpage>1339</fpage><lpage>45</lpage><pub-id pub-id-type="medline">15920049</pub-id><pub-id pub-id-type="pmid">15920049</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>N</given-names></name><name><surname>Gariépy</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>KJ</given-names></name><name><surname>Clyde</surname><given-names>M</given-names></name><name><surname>Malla</surname><given-names>A</given-names></name><name><surname>Boyer</surname><given-names>R</given-names></name><name><surname>Strychar</surname><given-names>I</given-names></name><name><surname>Lesage</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes</article-title><source>Diabetes Care</source><year>2014</year><month>4</month><volume>37</volume><issue>4</issue><fpage>970</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2337/dc13-1832</pub-id><pub-id pub-id-type="medline">24198303</pub-id><pub-id pub-id-type="pmid">24198303</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schram</surname><given-names>MT</given-names></name><name><surname>Baan</surname><given-names>CA</given-names></name><name><surname>Pouwer</surname><given-names>F</given-names></name></person-group><article-title>Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium</article-title><source>Curr Diabetes Rev</source><year>2009</year><month>5</month><volume>5</volume><issue>2</issue><fpage>112</fpage><lpage>9</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/19442096"></ext-link></comment><pub-id pub-id-type="medline">19442096</pub-id><pub-id pub-id-type="pmid">19442096</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>JS</given-names></name><name><surname>Delahanty</surname><given-names>LM</given-names></name><name><surname>Safren</surname><given-names>SA</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Grant</surname><given-names>RW</given-names></name></person-group><article-title>Differentiating symptoms of depression from diabetes-specific distress: relationships with self-care in type 2 diabetes</article-title><source>Diabetologia</source><year>2008</year><month>10</month><volume>51</volume><issue>10</issue><fpage>1822</fpage><lpage>5</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/18690422"></ext-link></comment><pub-id pub-id-type="doi">10.1007/s00125-008-1113-x</pub-id><pub-id pub-id-type="medline">18690422</pub-id><pub-id pub-id-type="pmid">18690422</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Smit</surname><given-names>F</given-names></name></person-group><article-title>Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies</article-title><source>Acta Psychiatr Scand</source><year>2004</year><month>5</month><volume>109</volume><issue>5</issue><fpage>325</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0447.2004.00301.x</pub-id><pub-id pub-id-type="medline">15049768</pub-id><pub-id pub-id-type="pmid">15049768</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snoek</surname><given-names>F</given-names></name><name><surname>Bremmer</surname><given-names>M</given-names></name><name><surname>Hermanns</surname><given-names>N</given-names></name></person-group><article-title>Constructs of depression and distress in diabetes: time for an appraisal</article-title><source>Lancet Diabetes Endocrinol</source><year>2015</year><month>6</month><volume>3</volume><issue>6</issue><fpage>450</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(15)00135-7</pub-id><pub-id pub-id-type="medline">25995123</pub-id><pub-id pub-id-type="pmid">25995123</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snoek</surname><given-names>FJ</given-names></name><name><surname>Pouwer</surname><given-names>F</given-names></name><name><surname>Welch</surname><given-names>GW</given-names></name><name><surname>Polonsky</surname><given-names>WH</given-names></name></person-group><article-title>Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale</article-title><source>Diabetes Care</source><year>2000</year><month>9</month><volume>23</volume><issue>9</issue><fpage>1305</fpage><lpage>9</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://care.diabetesjournals.org/cgi/pmidlookup?view=long&amp;pmid=10977023"></ext-link></comment><pub-id pub-id-type="medline">10977023</pub-id><pub-id pub-id-type="pmid">10977023</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snoek</surname><given-names>FJ</given-names></name><name><surname>Kersch</surname><given-names>NY</given-names></name><name><surname>Eldrup</surname><given-names>E</given-names></name><name><surname>Harman-Boehm</surname><given-names>I</given-names></name><name><surname>Hermanns</surname><given-names>N</given-names></name><name><surname>Kokoszka</surname><given-names>A</given-names></name><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>McGuire</surname><given-names>BE</given-names></name><name><surname>Pibernik-Okanovic</surname><given-names>M</given-names></name><name><surname>Singer</surname><given-names>J</given-names></name><name><surname>de Wit</surname><given-names>M</given-names></name><name><surname>Skovlund</surname><given-names>SE</given-names></name></person-group><article-title>Monitoring of Individual Needs in Diabetes (MIND): baseline data from the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study</article-title><source>Diabetes Care</source><year>2011</year><month>3</month><volume>34</volume><issue>3</issue><fpage>601</fpage><lpage>3</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/21266654"></ext-link></comment><pub-id pub-id-type="doi">10.2337/dc10-1552</pub-id><pub-id pub-id-type="medline">21266654</pub-id><pub-id pub-id-type="pmid">21266654</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>L</given-names></name><name><surname>Mullan</surname><given-names>JT</given-names></name><name><surname>Arean</surname><given-names>P</given-names></name><name><surname>Glasgow</surname><given-names>RE</given-names></name><name><surname>Hessler</surname><given-names>D</given-names></name><name><surname>Masharani</surname><given-names>U</given-names></name></person-group><article-title>Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses</article-title><source>Diabetes Care</source><year>2010</year><month>1</month><volume>33</volume><issue>1</issue><fpage>23</fpage><lpage>8</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/19837786"></ext-link></comment><pub-id pub-id-type="doi">10.2337/dc09-1238</pub-id><pub-id pub-id-type="medline">19837786</pub-id><pub-id pub-id-type="pmid">19837786</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>L</given-names></name><name><surname>Glasgow</surname><given-names>RE</given-names></name><name><surname>Strycker</surname><given-names>LA</given-names></name></person-group><article-title>The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes</article-title><source>Diabetes Care</source><year>2010</year><month>5</month><volume>33</volume><issue>5</issue><fpage>1034</fpage><lpage>6</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/20150291"></ext-link></comment><pub-id pub-id-type="doi">10.2337/dc09-2175</pub-id><pub-id pub-id-type="medline">20150291</pub-id><pub-id pub-id-type="pmid">20150291</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polonsky</surname><given-names>WH</given-names></name><name><surname>Anderson</surname><given-names>BJ</given-names></name><name><surname>Lohrer</surname><given-names>PA</given-names></name><name><surname>Welch</surname><given-names>G</given-names></name><name><surname>Jacobson</surname><given-names>AM</given-names></name><name><surname>Aponte</surname><given-names>JE</given-names></name><name><surname>Schwartz</surname><given-names>CE</given-names></name></person-group><article-title>Assessment of diabetes-related distress</article-title><source>Diabetes Care</source><year>1995</year><month>6</month><volume>18</volume><issue>6</issue><fpage>754</fpage><lpage>60</lpage><pub-id pub-id-type="medline">7555499</pub-id><pub-id pub-id-type="pmid">7555499</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrmann</surname><given-names>D</given-names></name><name><surname>Kulzer</surname><given-names>B</given-names></name><name><surname>Haak</surname><given-names>T</given-names></name><name><surname>Hermanns</surname><given-names>N</given-names></name></person-group><article-title>Longitudinal relationship of diabetes-related distress and depressive symptoms: analysing incidence and persistence</article-title><source>Diabet Med</source><year>2015</year><month>10</month><volume>32</volume><issue>10</issue><fpage>1264</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1111/dme.12861</pub-id><pub-id pub-id-type="medline">26202341</pub-id><pub-id pub-id-type="pmid">26202341</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>International Diabetes Federation Clinical Guidelines Taskforce</collab></person-group><source>International Diabetes Federation Communications</source><year>2016</year><date-in-citation>2016-12-11</date-in-citation><comment>Global guideline for type 2 diabetes
<ext-link ext-link-type="uri" xlink:href="http://www.idf.org/sites/default/files/IDF-Guideline-for-Type-2-Diabetes.pdf">http://www.idf.org/sites/default/files/IDF-Guideline-for-Type-2-Diabetes.pdf</ext-link><ext-link ext-link-type="webcite" xlink:href="6mfpgVWcs"></ext-link></comment></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermanns</surname><given-names>N</given-names></name><name><surname>Kulzer</surname><given-names>B</given-names></name><name><surname>Krichbaum</surname><given-names>M</given-names></name><name><surname>Kubiak</surname><given-names>T</given-names></name><name><surname>Haak</surname><given-names>T</given-names></name></person-group><article-title>How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment</article-title><source>Diabetologia</source><year>2006</year><month>3</month><volume>49</volume><issue>3</issue><fpage>469</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s00125-005-0094-2</pub-id><pub-id pub-id-type="medline">16432706</pub-id><pub-id pub-id-type="pmid">16432706</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermanns</surname><given-names>N</given-names></name><name><surname>Caputo</surname><given-names>S</given-names></name><name><surname>Dzida</surname><given-names>G</given-names></name><name><surname>Khunti</surname><given-names>K</given-names></name><name><surname>Meneghini</surname><given-names>LF</given-names></name><name><surname>Snoek</surname><given-names>F</given-names></name></person-group><article-title>Screening, evaluation and management of depression in people with diabetes in primary care</article-title><source>Prim Care Diabetes</source><year>2013</year><month>4</month><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://linkinghub.elsevier.com/retrieve/pii/S1751-9918(12)00222-7"></ext-link></comment><pub-id pub-id-type="doi">10.1016/j.pcd.2012.11.002</pub-id><pub-id pub-id-type="medline">23280258</pub-id><pub-id pub-id-type="pmid">23280258</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrak</surname><given-names>F</given-names></name><name><surname>Baumeister</surname><given-names>H</given-names></name><name><surname>Skinner</surname><given-names>TC</given-names></name><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Holt</surname><given-names>RI</given-names></name></person-group><article-title>Depression and diabetes: treatment and health-care delivery</article-title><source>Lancet Diabetes Endocrinol</source><year>2015</year><month>6</month><volume>3</volume><issue>6</issue><fpage>472</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(15)00045-5</pub-id><pub-id pub-id-type="medline">25995125</pub-id><pub-id pub-id-type="pmid">25995125</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>NHS Diabetes</collab><collab>Diabetes UK</collab></person-group><source>Emotional and psychological care and support in diabetes: Report from the emotional and psychological support working group of NHS Diabetes and Diabetes UK</source><year>2010</year><date-in-citation>2016-12-12</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://www.diabetes.org.uk/Documents/Reports/Emotional_and_Psychological_Support_and_Care_in_Diabetes_2010.pdf">https://www.diabetes.org.uk/Documents/Reports/Emotional_and_Psychological_Support_and_Care_in_Diabetes_2010.pdf</ext-link><ext-link ext-link-type="webcite" xlink:href="6mfq7sEvk"></ext-link></comment></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moock</surname><given-names>J</given-names></name></person-group><article-title>Support from the Internet for individuals with mental disorders: advantages and disadvantages of e-mental health service delivery</article-title><source>Front Public Health</source><year>2014</year><volume>2</volume><fpage>65</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.3389/fpubh.2014.00065"></ext-link></comment><pub-id pub-id-type="doi">10.3389/fpubh.2014.00065</pub-id><pub-id pub-id-type="medline">24967221</pub-id><pub-id pub-id-type="pmid">24967221</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassimatis</surname><given-names>M</given-names></name><name><surname>Kavanagh</surname><given-names>DJ</given-names></name><name><surname>Hills</surname><given-names>AP</given-names></name><name><surname>Smith</surname><given-names>AC</given-names></name><name><surname>Scuffham</surname><given-names>PA</given-names></name><name><surname>Edge</surname><given-names>S</given-names></name><name><surname>Gibson</surname><given-names>J</given-names></name><name><surname>Gericke</surname><given-names>C</given-names></name></person-group><article-title>Development of the OnTrack Diabetes Program</article-title><source>JMIR Res Protoc</source><year>2015</year><volume>4</volume><issue>2</issue><fpage>e24</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.researchprotocols.org/2015/2/e24/"></ext-link></comment><pub-id pub-id-type="doi">10.2196/resprot.2823</pub-id><pub-id pub-id-type="medline">26013840</pub-id><pub-id pub-id-type="pmid">26013840</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>E</given-names></name><name><surname>Schaper</surname><given-names>N</given-names></name><name><surname>de Vries</surname><given-names>N</given-names></name></person-group><article-title>Self-management interventions for type 2 diabetes: a systematic review</article-title><source>European Diabetes Nursing</source><year>2015</year><month>2</month><day>17</day><volume>7</volume><issue>2</issue><fpage>71</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1002/edn.160</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Proudfoot</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name></person-group><article-title>Mobile phone and web-based cognitive behavior therapy for depressive symptoms and mental health comorbidities in people living with diabetes: results of a feasibility study</article-title><source>JMIR Ment Health</source><year>2016</year><month>5</month><day>31</day><volume>3</volume><issue>2</issue><fpage>e23</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://mental.jmir.org/2016/2/e23/"></ext-link></comment><pub-id pub-id-type="doi">10.2196/mental.5131</pub-id><pub-id pub-id-type="medline">27245948</pub-id><pub-id pub-id-type="pmid">27245948</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>L</given-names></name><name><surname>Hessler</surname><given-names>D</given-names></name><name><surname>Glasgow</surname><given-names>RE</given-names></name><name><surname>Arean</surname><given-names>PA</given-names></name><name><surname>Masharani</surname><given-names>U</given-names></name><name><surname>Naranjo</surname><given-names>D</given-names></name><name><surname>Strycker</surname><given-names>LA</given-names></name></person-group><article-title>REDEEM: a pragmatic trial to reduce diabetes distress</article-title><source>Diabetes Care</source><year>2013</year><month>9</month><volume>36</volume><issue>9</issue><fpage>2551</fpage><lpage>8</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/23735726"></ext-link></comment><pub-id pub-id-type="doi">10.2337/dc12-2493</pub-id><pub-id pub-id-type="medline">23735726</pub-id><pub-id pub-id-type="pmid">23735726</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Bastelaar</surname><given-names>KM</given-names></name><name><surname>Pouwer</surname><given-names>F</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Riper</surname><given-names>H</given-names></name><name><surname>Snoek</surname><given-names>FJ</given-names></name></person-group><article-title>Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial</article-title><source>Diabetes Care</source><year>2011</year><month>2</month><volume>34</volume><issue>2</issue><fpage>320</fpage><lpage>5</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/21216855"></ext-link></comment><pub-id pub-id-type="doi">10.2337/dc10-1248</pub-id><pub-id pub-id-type="medline">21216855</pub-id><pub-id pub-id-type="pmid">21216855</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyssen</surname><given-names>OP</given-names></name><name><surname>Taylor</surname><given-names>SJ</given-names></name><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Steed</surname><given-names>E</given-names></name><name><surname>Bourke</surname><given-names>L</given-names></name><name><surname>Lord</surname><given-names>J</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Hayman</surname><given-names>S</given-names></name><name><surname>Field</surname><given-names>V</given-names></name><name><surname>Higgins</surname><given-names>A</given-names></name><name><surname>Greenhalgh</surname><given-names>T</given-names></name><name><surname>Meads</surname><given-names>C</given-names></name></person-group><article-title>Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations</article-title><source>Health Technol Assess</source><year>2016</year><month>4</month><volume>20</volume><issue>27</issue><fpage>vii</fpage><lpage>xxxvii, 1</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.3310/hta20270"></ext-link></comment><pub-id pub-id-type="doi">10.3310/hta20270</pub-id><pub-id pub-id-type="medline">27071807</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennebaker</surname><given-names>JW</given-names></name><name><surname>Beall</surname><given-names>SK</given-names></name></person-group><article-title>Confronting a traumatic event: toward an understanding of inhibition and disease</article-title><source>J Abnorm Psychol</source><year>1986</year><month>8</month><volume>95</volume><issue>3</issue><fpage>274</fpage><lpage>81</lpage><pub-id pub-id-type="medline">3745650</pub-id><pub-id pub-id-type="pmid">3745650</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frattaroli</surname><given-names>J</given-names></name></person-group><article-title>Experimental disclosure and its moderators: a meta-analysis</article-title><source>Psychol Bull</source><year>2006</year><month>11</month><volume>132</volume><issue>6</issue><fpage>823</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1037/0033-2909.132.6.823</pub-id><pub-id pub-id-type="medline">17073523</pub-id><pub-id pub-id-type="pmid">17073523</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gortner</surname><given-names>E</given-names></name><name><surname>Rude</surname><given-names>SS</given-names></name><name><surname>Pennebaker</surname><given-names>JW</given-names></name></person-group><article-title>Benefits of expressive writing in lowering rumination and depressive symptoms</article-title><source>Behav Ther</source><year>2006</year><month>9</month><volume>37</volume><issue>3</issue><fpage>292</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.beth.2006.01.004</pub-id><pub-id pub-id-type="medline">16942980</pub-id><pub-id pub-id-type="pmid">16942980</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krpan</surname><given-names>KM</given-names></name><name><surname>Kross</surname><given-names>E</given-names></name><name><surname>Berman</surname><given-names>MG</given-names></name><name><surname>Deldin</surname><given-names>PJ</given-names></name><name><surname>Askren</surname><given-names>MK</given-names></name><name><surname>Jonides</surname><given-names>J</given-names></name></person-group><article-title>An everyday activity as a treatment for depression: the benefits of expressive writing for people diagnosed with major depressive disorder</article-title><source>J Affect Disord</source><year>2013</year><month>9</month><day>25</day><volume>150</volume><issue>3</issue><fpage>1148</fpage><lpage>51</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/23790815"></ext-link></comment><pub-id pub-id-type="doi">10.1016/j.jad.2013.05.065</pub-id><pub-id pub-id-type="medline">23790815</pub-id><pub-id pub-id-type="pmid">23790815</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alparone</surname><given-names>FR</given-names></name><name><surname>Pagliaro</surname><given-names>S</given-names></name><name><surname>Rizzo</surname><given-names>I</given-names></name></person-group><article-title>The words to tell their own pain: linguistic markers of cognitive reappraisal in mediating benefits of expressive writing</article-title><source>J Soc Clin Psychol</source><year>2015</year><month>6</month><volume>34</volume><issue>6</issue><fpage>495</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1521/jscp.2015.34.6.495</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloan</surname><given-names>DM</given-names></name><name><surname>Marx</surname><given-names>BP</given-names></name><name><surname>Epstein</surname><given-names>EM</given-names></name></person-group><article-title>Further examination of the exposure model underlying the efficacy of written emotional disclosure</article-title><source>J Consult Clin Psychol</source><year>2005</year><month>6</month><volume>73</volume><issue>3</issue><fpage>549</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.73.3.549</pub-id><pub-id pub-id-type="medline">15982152</pub-id><pub-id pub-id-type="pmid">15982152</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloan</surname><given-names>DM</given-names></name><name><surname>Marx</surname><given-names>BP</given-names></name><name><surname>Epstein</surname><given-names>EM</given-names></name><name><surname>Lexington</surname><given-names>JM</given-names></name></person-group><article-title>Does altering the writing instructions influence outcome associated with written disclosure?</article-title><source>Behav Ther</source><year>2007</year><month>6</month><volume>38</volume><issue>2</issue><fpage>155</fpage><lpage>68</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/17499082"></ext-link></comment><pub-id pub-id-type="doi">10.1016/j.beth.2006.06.005</pub-id><pub-id pub-id-type="medline">17499082</pub-id><pub-id pub-id-type="pmid">17499082</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>JM</given-names></name></person-group><article-title>Written emotional expression: effect sizes, outcome types, and moderating variables</article-title><source>J Consult Clin Psychol</source><year>1998</year><month>2</month><volume>66</volume><issue>1</issue><fpage>174</fpage><lpage>84</lpage><pub-id pub-id-type="medline">9489272</pub-id><pub-id pub-id-type="pmid">9489272</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrie</surname><given-names>KJ</given-names></name><name><surname>Fontanilla</surname><given-names>I</given-names></name><name><surname>Thomas</surname><given-names>MG</given-names></name><name><surname>Booth</surname><given-names>RJ</given-names></name><name><surname>Pennebaker</surname><given-names>JW</given-names></name></person-group><article-title>Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial</article-title><source>Psychosom Med</source><year>2004</year><volume>66</volume><issue>2</issue><fpage>272</fpage><lpage>5</lpage><pub-id pub-id-type="medline">15039514</pub-id><pub-id pub-id-type="pmid">15039514</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danoff-Burg</surname><given-names>S</given-names></name><name><surname>Agee</surname><given-names>JD</given-names></name><name><surname>Romanoff</surname><given-names>NR</given-names></name><name><surname>Kremer</surname><given-names>JM</given-names></name><name><surname>Strosberg</surname><given-names>JM</given-names></name></person-group><article-title>Benefit finding and expressive writing in adults with lupus or rheumatoid arthritis</article-title><source>Psychol Health</source><year>2006</year><month>10</month><volume>21</volume><issue>5</issue><fpage>651</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1080/14768320500456996</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanton</surname><given-names>AL</given-names></name><name><surname>Danoff-Burg</surname><given-names>S</given-names></name><name><surname>Sworowski</surname><given-names>LA</given-names></name><name><surname>Collins</surname><given-names>CA</given-names></name><name><surname>Branstetter</surname><given-names>AD</given-names></name><name><surname>Rodriguez-Hanley</surname><given-names>A</given-names></name><name><surname>Kirk</surname><given-names>SB</given-names></name><name><surname>Austenfeld</surname><given-names>JL</given-names></name></person-group><article-title>Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients</article-title><source>J Clin Oncol</source><year>2002</year><month>10</month><day>15</day><volume>20</volume><issue>20</issue><fpage>4160</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1200/JCO.2002.08.521</pub-id><pub-id pub-id-type="medline">12377959</pub-id><pub-id pub-id-type="pmid">12377959</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kliewer</surname><given-names>W</given-names></name><name><surname>Lepore</surname><given-names>SJ</given-names></name><name><surname>Farrell</surname><given-names>AD</given-names></name><name><surname>Allison</surname><given-names>KW</given-names></name><name><surname>Meyer</surname><given-names>AL</given-names></name><name><surname>Sullivan</surname><given-names>TN</given-names></name><name><surname>Greene</surname><given-names>AY</given-names></name></person-group><article-title>A school-based expressive writing intervention for at-risk urban adolescents' aggressive behavior and emotional lability</article-title><source>J Clin Child Adolesc Psychol</source><year>2011</year><volume>40</volume><issue>5</issue><fpage>693</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1080/15374416.2011.597092</pub-id><pub-id pub-id-type="medline">21916688</pub-id><pub-id pub-id-type="pmid">21916688</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>G</given-names></name><name><surname>Beilock</surname><given-names>SL</given-names></name></person-group><article-title>Writing about testing worries boosts exam performance in the classroom</article-title><source>Science</source><year>2011</year><month>1</month><day>14</day><volume>331</volume><issue>6014</issue><fpage>211</fpage><lpage>3</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.sciencemag.org/cgi/pmidlookup?view=long&amp;pmid=21233387"></ext-link></comment><pub-id pub-id-type="doi">10.1126/science.1199427</pub-id><pub-id pub-id-type="medline">21233387</pub-id><pub-id pub-id-type="pmid">21233387</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisina</surname><given-names>PG</given-names></name><name><surname>Borod</surname><given-names>JC</given-names></name><name><surname>Lepore</surname><given-names>SJ</given-names></name></person-group><article-title>A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations</article-title><source>J Nerv Ment Dis</source><year>2004</year><month>9</month><volume>192</volume><issue>9</issue><fpage>629</fpage><lpage>34</lpage><pub-id pub-id-type="medline">15348980</pub-id><pub-id pub-id-type="pmid">15348980</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baikie</surname><given-names>KA</given-names></name><name><surname>Wilhelm</surname><given-names>K</given-names></name></person-group><article-title>Emotional and physical health benefits of expressive writing</article-title><source>Adv Psychiatr Treat</source><year>2005</year><month>9</month><day>01</day><volume>11</volume><issue>5</issue><fpage>338</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1192/apt.11.5.338</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastella</surname><given-names>AJ</given-names></name><name><surname>Dadds</surname><given-names>MR</given-names></name></person-group><article-title>Cognitive-behavioural emotion writing tasks: a controlled trial of multiple processes</article-title><source>J Behav Ther Exp Psychiatry</source><year>2008</year><month>12</month><volume>39</volume><issue>4</issue><fpage>558</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.jbtep.2007.11.008</pub-id><pub-id pub-id-type="medline">18346712</pub-id><pub-id pub-id-type="pmid">18346712</pub-id></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Bodor NZ</collab></person-group><source>The health effects of emotional disclosure for individuals with type 1 diabetes</source><year>2002</year><date-in-citation>2016-12-11</date-in-citation><publisher-loc>Austin</publisher-loc><publisher-name>University of Texas</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://repositories.lib.utexas.edu/handle/2152/11914">https://repositories.lib.utexas.edu/handle/2152/11914</ext-link><ext-link ext-link-type="webcite" xlink:href="6mfqeTwoh"></ext-link></comment></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennick</surname><given-names>K</given-names></name><name><surname>Bridle</surname><given-names>C</given-names></name><name><surname>Sturt</surname><given-names>J</given-names></name></person-group><article-title>Written emotional disclosure for adults with type 2 diabetes: a primary care feasibility study</article-title><source>Prim Health Care Res Dev</source><year>2015</year><month>4</month><volume>16</volume><issue>2</issue><fpage>179</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1017/S1463423614000188</pub-id><pub-id pub-id-type="medline">24801108</pub-id><pub-id pub-id-type="pmid">24801108</pub-id></element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewandowski</surname><given-names>GW</given-names></name></person-group><article-title>Promoting positive emotions following relationship dissolution through writing</article-title><source>J Posit Psychol</source><year>2009</year><month>1</month><volume>4</volume><issue>1</issue><fpage>21</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1080/17439760802068480</pub-id></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoni</surname><given-names>MH</given-names></name><name><surname>Lehman</surname><given-names>JM</given-names></name><name><surname>Kilbourn</surname><given-names>KM</given-names></name><name><surname>Boyers</surname><given-names>AE</given-names></name><name><surname>Culver</surname><given-names>JL</given-names></name><name><surname>Alferi</surname><given-names>SM</given-names></name><name><surname>Yount</surname><given-names>SE</given-names></name><name><surname>McGregor</surname><given-names>BA</given-names></name><name><surname>Arena</surname><given-names>PL</given-names></name><name><surname>Harris</surname><given-names>SD</given-names></name><name><surname>Price</surname><given-names>AA</given-names></name><name><surname>Carver</surname><given-names>CS</given-names></name></person-group><article-title>Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer</article-title><source>Health Psychol</source><year>2001</year><month>1</month><volume>20</volume><issue>1</issue><fpage>20</fpage><lpage>32</lpage><pub-id pub-id-type="medline">11199062</pub-id><pub-id pub-id-type="pmid">11199062</pub-id></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helgeson</surname><given-names>VS</given-names></name><name><surname>Reynolds</surname><given-names>KA</given-names></name><name><surname>Tomich</surname><given-names>PL</given-names></name></person-group><article-title>A meta-analytic review of benefit finding and growth</article-title><source>J Consult Clin Psychol</source><year>2006</year><month>10</month><volume>74</volume><issue>5</issue><fpage>797</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.74.5.797</pub-id><pub-id pub-id-type="medline">17032085</pub-id><pub-id pub-id-type="pmid">17032085</pub-id></element-citation></ref><ref id="ref53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tedeschi</surname><given-names>RG</given-names></name><name><surname>Calhoun</surname><given-names>LG</given-names></name></person-group><article-title>The Posttraumatic Growth Inventory: measuring the positive legacy of trauma</article-title><source>J Trauma Stress</source><year>1996</year><month>7</month><volume>9</volume><issue>3</issue><fpage>455</fpage><lpage>71</lpage><pub-id pub-id-type="medline">8827649</pub-id><pub-id pub-id-type="pmid">8827649</pub-id></element-citation></ref><ref id="ref54"><label>54</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Algoe</surname><given-names>SB</given-names></name><name><surname>Stanton</surname><given-names>AL</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Park</surname><given-names>CL</given-names></name><name><surname>Lechner</surname><given-names>SC</given-names></name><name><surname>Antoni</surname><given-names>MH</given-names></name><name><surname>Stanton</surname><given-names>AL</given-names></name></person-group><article-title>Is benefit finding good for individuals with chronic disease?</article-title><source>Medical Illness and Positive Life Change: Can Crisis Lead to Personal Transformation</source><year>2009</year><publisher-loc>Washington DC</publisher-loc><publisher-name>American Psychological Association</publisher-name><fpage>173</fpage><lpage>193</lpage></element-citation></ref><ref id="ref55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>V</given-names></name><name><surname>Wiebe</surname><given-names>DJ</given-names></name><name><surname>Fortenberry</surname><given-names>KT</given-names></name><name><surname>Butler</surname><given-names>JM</given-names></name><name><surname>Berg</surname><given-names>CA</given-names></name></person-group><article-title>Benefit finding, affective reactions to diabetes stress, and diabetes management among early adolescents</article-title><source>Health Psychol</source><year>2011</year><month>3</month><volume>30</volume><issue>2</issue><fpage>212</fpage><lpage>9</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/21401255"></ext-link></comment><pub-id pub-id-type="doi">10.1037/a0022378</pub-id><pub-id pub-id-type="medline">21401255</pub-id><pub-id pub-id-type="pmid">21401255</pub-id></element-citation></ref><ref id="ref56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>SL</given-names></name><name><surname>Vella</surname><given-names>L</given-names></name><name><surname>Mohr</surname><given-names>DC</given-names></name></person-group><article-title>Relationships among depressive symptoms, benefit-finding, optimism, and positive affect in multiple sclerosis patients after psychotherapy for depression</article-title><source>Health Psychol</source><year>2008</year><month>3</month><volume>27</volume><issue>2</issue><fpage>230</fpage><lpage>8</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/18377142"></ext-link></comment><pub-id pub-id-type="doi">10.1037/0278-6133.27.2.230</pub-id><pub-id pub-id-type="medline">18377142</pub-id><pub-id pub-id-type="pmid">18377142</pub-id></element-citation></ref><ref id="ref57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luszczynska</surname><given-names>A</given-names></name><name><surname>Mohamed</surname><given-names>NE</given-names></name><name><surname>Schwarzer</surname><given-names>R</given-names></name></person-group><article-title>Self-efficacy and social support predict benefit finding 12 months after cancer surgery: the mediating role of coping strategies</article-title><source>Psychol Health Med</source><year>2005</year><month>11</month><volume>10</volume><issue>4</issue><fpage>365</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1080/13548500500093738</pub-id></element-citation></ref><ref id="ref58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helgeson</surname><given-names>VS</given-names></name><name><surname>Becker</surname><given-names>D</given-names></name><name><surname>Escobar</surname><given-names>O</given-names></name><name><surname>Siminerio</surname><given-names>L</given-names></name></person-group><article-title>Families with children with diabetes: implications of parent stress for parent and child health</article-title><source>J Pediatr Psychol</source><year>2012</year><month>5</month><volume>37</volume><issue>4</issue><fpage>467</fpage><lpage>78</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://jpepsy.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=22267104"></ext-link></comment><pub-id pub-id-type="doi">10.1093/jpepsy/jsr110</pub-id><pub-id pub-id-type="medline">22267104</pub-id><pub-id pub-id-type="pmid">22267104</pub-id></element-citation></ref><ref id="ref59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facchin</surname><given-names>F</given-names></name><name><surname>Margola</surname><given-names>D</given-names></name><name><surname>Molgora</surname><given-names>S</given-names></name><name><surname>Revenson</surname><given-names>TA</given-names></name></person-group><article-title>Effects of benefit-focused versus standard expressive writing on adolescents' self-concept during the high school transition</article-title><source>J Res Adolesc</source><year>2013</year><month>3</month><day>25</day><volume>24</volume><issue>1</issue><fpage>131</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1111/jora.12040</pub-id></element-citation></ref><ref id="ref60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastella</surname><given-names>AJ</given-names></name><name><surname>Dadds</surname><given-names>MR</given-names></name></person-group><article-title>Cognitive-behavioral models of emotional writing: a validation study</article-title><source>Cogn Ther Res</source><year>2006</year><month>10</month><day>10</day><volume>30</volume><issue>3</issue><fpage>397</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1007/s10608-006-9045-6</pub-id></element-citation></ref><ref id="ref61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazarian</surname><given-names>D</given-names></name><name><surname>Smyth</surname><given-names>JM</given-names></name></person-group><article-title>An experimental test of instructional manipulations in expressive writing interventions: examining processes of change</article-title><source>J Soc Clin Psychol</source><year>2013</year><month>1</month><volume>32</volume><issue>1</issue><fpage>71</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1521/jscp.2013.32.1.71</pub-id></element-citation></ref><ref id="ref62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenthal</surname><given-names>WG</given-names></name><name><surname>Cruess</surname><given-names>DG</given-names></name></person-group><article-title>Effects of directed written disclosure on grief and distress symptoms among bereaved individuals</article-title><source>Death Stud</source><year>2010</year><month>7</month><volume>34</volume><issue>6</issue><fpage>475</fpage><lpage>99</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/24482856"></ext-link></comment><pub-id pub-id-type="doi">10.1080/07481187.2010.483332</pub-id><pub-id pub-id-type="medline">24482856</pub-id><pub-id pub-id-type="pmid">24482856</pub-id></element-citation></ref><ref id="ref63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baikie</surname><given-names>KA</given-names></name><name><surname>Geerligs</surname><given-names>L</given-names></name><name><surname>Wilhelm</surname><given-names>K</given-names></name></person-group><article-title>Expressive writing and positive writing for participants with mood disorders: an online randomized controlled trial</article-title><source>J Affect Disord</source><year>2012</year><month>2</month><volume>136</volume><issue>3</issue><fpage>310</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2011.11.032</pub-id><pub-id pub-id-type="medline">22209127</pub-id><pub-id pub-id-type="pmid">22209127</pub-id></element-citation></ref><ref id="ref64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Possemato</surname><given-names>K</given-names></name><name><surname>Ouimette</surname><given-names>P</given-names></name><name><surname>Geller</surname><given-names>PA</given-names></name></person-group><article-title>Internet-based expressive writing for kidney transplant recipients: effects on posttraumatic stress and quality of life</article-title><source>Traumatology</source><year>2010</year><volume>16</volume><issue>1</issue><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1177/1534765609347545</pub-id></element-citation></ref><ref id="ref65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halpert</surname><given-names>A</given-names></name><name><surname>Rybin</surname><given-names>D</given-names></name><name><surname>Doros</surname><given-names>G</given-names></name></person-group><article-title>Expressive writing is a promising therapeutic modality for the management of IBS: a pilot study</article-title><source>Am J Gastroenterol</source><year>2010</year><month>11</month><volume>105</volume><issue>11</issue><fpage>2440</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/ajg.2010.246</pub-id><pub-id pub-id-type="medline">20551938</pub-id><pub-id pub-id-type="pmid">20551938</pub-id></element-citation></ref><ref id="ref66"><label>66</label><element-citation publication-type="book"><source>Writing for Health</source><year>2017</year><date-in-citation>2017-03-05</date-in-citation><publisher-loc>Sydney, Australia</publisher-loc><publisher-name>University of New South Wales and St. Vincent’s Hospital</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://writingforhealth.ehat.com.au">https://writingforhealth.ehat.com.au</ext-link><ext-link ext-link-type="webcite" xlink:href="6okaeFqOq"></ext-link></comment></element-citation></ref><ref id="ref67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polonsky</surname><given-names>WH</given-names></name><name><surname>Fisher</surname><given-names>L</given-names></name><name><surname>Earles</surname><given-names>J</given-names></name><name><surname>Dudl</surname><given-names>RJ</given-names></name><name><surname>Lees</surname><given-names>J</given-names></name><name><surname>Mullan</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>RA</given-names></name></person-group><article-title>Assessing psychosocial distress in diabetes: development of the diabetes distress scale</article-title><source>Diabetes Care</source><year>2005</year><month>3</month><volume>28</volume><issue>3</issue><fpage>626</fpage><lpage>31</lpage><pub-id pub-id-type="medline">15735199</pub-id><pub-id pub-id-type="pmid">15735199</pub-id></element-citation></ref><ref id="ref68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>L</given-names></name><name><surname>Hessler</surname><given-names>DM</given-names></name><name><surname>Polonsky</surname><given-names>WH</given-names></name><name><surname>Mullan</surname><given-names>J</given-names></name></person-group><article-title>When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale</article-title><source>Diabetes Care</source><year>2012</year><month>2</month><volume>35</volume><issue>2</issue><fpage>259</fpage><lpage>64</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/22228744"></ext-link></comment><pub-id pub-id-type="doi">10.2337/dc11-1572</pub-id><pub-id pub-id-type="medline">22228744</pub-id><pub-id pub-id-type="pmid">22228744</pub-id></element-citation></ref><ref id="ref69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name></person-group><article-title>The PHQ-9: validity of a brief depression severity measure</article-title><source>J Gen Intern Med</source><year>2001</year><month>9</month><volume>16</volume><issue>9</issue><fpage>606</fpage><lpage>13</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/11556941"></ext-link></comment><pub-id pub-id-type="medline">11556941</pub-id><pub-id pub-id-type="pmid">11556941</pub-id></element-citation></ref><ref id="ref70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Löwe</surname><given-names>B</given-names></name></person-group><article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title><source>Arch Intern Med</source><year>2006</year><month>5</month><day>22</day><volume>166</volume><issue>10</issue><fpage>1092</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/archinte.166.10.1092</pub-id><pub-id pub-id-type="medline">16717171</pub-id><pub-id pub-id-type="pmid">16717171</pub-id></element-citation></ref><ref id="ref71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Monahan</surname><given-names>PO</given-names></name><name><surname>Löwe</surname><given-names>B</given-names></name></person-group><article-title>Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection</article-title><source>Ann Intern Med</source><year>2007</year><month>3</month><day>6</day><volume>146</volume><issue>5</issue><fpage>317</fpage><lpage>25</lpage><pub-id pub-id-type="medline">17339617</pub-id><pub-id pub-id-type="pmid">17339617</pub-id></element-citation></ref><ref id="ref72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>ER</given-names></name></person-group><article-title>Development and validation of an internationally reliable short-form of the Positive and Negative Affect Schedule (PANAS)</article-title><source>J Cross Cult Psychol</source><year>2007</year><month>3</month><day>01</day><volume>38</volume><issue>2</issue><fpage>227</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1177/0022022106297301</pub-id></element-citation></ref><ref id="ref73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>D</given-names></name><name><surname>Clark</surname><given-names>LA</given-names></name><name><surname>Tellegen</surname><given-names>A</given-names></name></person-group><article-title>Development and validation of brief measures of positive and negative affect: the PANAS scales</article-title><source>J Pers Soc Psychol</source><year>1988</year><month>6</month><volume>54</volume><issue>6</issue><fpage>1063</fpage><lpage>70</lpage><pub-id pub-id-type="medline">3397865</pub-id><pub-id pub-id-type="pmid">3397865</pub-id></element-citation></ref><ref id="ref74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toobert</surname><given-names>DJ</given-names></name><name><surname>Hampson</surname><given-names>SE</given-names></name><name><surname>Glasgow</surname><given-names>RE</given-names></name></person-group><article-title>The summary of diabetes self-care activities measure: results from 7 studies and a revised scale</article-title><source>Diabetes Care</source><year>2000</year><month>7</month><volume>23</volume><issue>7</issue><fpage>943</fpage><lpage>50</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://care.diabetesjournals.org/cgi/pmidlookup?view=long&amp;pmid=10895844"></ext-link></comment><pub-id pub-id-type="medline">10895844</pub-id><pub-id pub-id-type="pmid">10895844</pub-id></element-citation></ref><ref id="ref75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eigenmann</surname><given-names>CA</given-names></name><name><surname>Colagiuri</surname><given-names>R</given-names></name><name><surname>Skinner</surname><given-names>TC</given-names></name><name><surname>Trevena</surname><given-names>L</given-names></name></person-group><article-title>Are current psychometric tools suitable for measuring outcomes of diabetes education?</article-title><source>Diabet Med</source><year>2009</year><month>4</month><volume>26</volume><issue>4</issue><fpage>425</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2009.02697.x</pub-id><pub-id pub-id-type="medline">19388974</pub-id><pub-id pub-id-type="pmid">19388974</pub-id></element-citation></ref><ref id="ref76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>AB</given-names></name><name><surname>Gannik</surname><given-names>D</given-names></name><name><surname>Siersma</surname><given-names>V</given-names></name><name><surname>Niels de Fine</surname><given-names>O</given-names></name></person-group><article-title>The relationship between HbA1c level, symptoms and self-rated health in type 2 diabetic patients</article-title><source>Scand J Prim Health Care</source><year>2011</year><month>9</month><volume>29</volume><issue>3</issue><fpage>157</fpage><lpage>64</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/21707235"></ext-link></comment><pub-id pub-id-type="doi">10.3109/02813432.2011.585542</pub-id><pub-id pub-id-type="medline">21707235</pub-id><pub-id pub-id-type="pmid">21707235</pub-id></element-citation></ref><ref id="ref77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lepore</surname><given-names>SJ</given-names></name></person-group><article-title>Expressive writing moderates the relation between intrusive thoughts and depressive symptoms</article-title><source>J Pers Soc Psychol</source><year>1997</year><month>11</month><volume>73</volume><issue>5</issue><fpage>1030</fpage><lpage>7</lpage><pub-id pub-id-type="medline">9364758</pub-id><pub-id pub-id-type="pmid">9364758</pub-id></element-citation></ref><ref id="ref78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorndike</surname><given-names>FP</given-names></name><name><surname>Saylor</surname><given-names>DK</given-names></name><name><surname>Bailey</surname><given-names>ET</given-names></name><name><surname>Gonder-Frederick</surname><given-names>L</given-names></name><name><surname>Morin</surname><given-names>CM</given-names></name><name><surname>Ritterband</surname><given-names>LM</given-names></name></person-group><article-title>Development and perceived utility and impact of an Internet intervention for insomnia</article-title><source>E J Appl Psychol</source><year>2008</year><volume>4</volume><issue>2</issue><fpage>32</fpage><lpage>42</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/20953264"></ext-link></comment><pub-id pub-id-type="medline">20953264</pub-id><pub-id pub-id-type="pmid">20953264</pub-id></element-citation></ref><ref id="ref79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazarian</surname><given-names>D</given-names></name><name><surname>Smyth</surname><given-names>JM</given-names></name></person-group><article-title>Context moderates the effects of an expressive writing intervention: a randomized two-study replication and extension</article-title><source>J Soc Clin Psychol</source><year>2010</year><month>10</month><volume>29</volume><issue>8</issue><fpage>903</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1521/jscp.2010.29.8.903</pub-id></element-citation></ref><ref id="ref80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzoni</surname><given-names>GM</given-names></name><name><surname>Castelnuovo</surname><given-names>G</given-names></name><name><surname>Molinari</surname><given-names>E</given-names></name></person-group><article-title>The WRITTEN-HEART study (expressive writing for heart healing): rationale and design of a randomized controlled clinical trial of expressive writing in coronary patients referred to residential cardiac rehabilitation</article-title><source>Health Qual Life Outcomes</source><year>2011</year><month>7</month><day>08</day><volume>9</volume><fpage>51</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://hqlo.biomedcentral.com/articles/10.1186/1477-7525-9-51"></ext-link></comment><pub-id pub-id-type="doi">10.1186/1477-7525-9-51</pub-id><pub-id pub-id-type="medline">21740564</pub-id><pub-id pub-id-type="pmid">21740564</pub-id></element-citation></ref><ref id="ref81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Vatiliotis</surname><given-names>V</given-names></name><name><surname>Verge</surname><given-names>CF</given-names></name><name><surname>Holmes-Walker</surname><given-names>J</given-names></name><name><surname>Campbell</surname><given-names>LV</given-names></name><name><surname>Wilhelm</surname><given-names>K</given-names></name><name><surname>Proudfoot</surname><given-names>J</given-names></name></person-group><article-title>A mobile phone and web-based intervention for improving mental well-being in young people with type 1 diabetes: design of a randomized controlled trial</article-title><source>JMIR Res Protoc</source><year>2015</year><volume>4</volume><issue>2</issue><fpage>e50</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.researchprotocols.org/2015/2/e50/"></ext-link></comment><pub-id pub-id-type="doi">10.2196/resprot.4032</pub-id><pub-id pub-id-type="medline">25944212</pub-id><pub-id pub-id-type="pmid">25944212</pub-id></element-citation></ref><ref id="ref82"><label>82</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pennebaker</surname><given-names>JW</given-names></name><name><surname>Chung</surname><given-names>CK</given-names></name><name><surname>Ireland</surname><given-names>M</given-names></name><name><surname>Gonzales</surname><given-names>A</given-names></name><name><surname>Booth</surname><given-names>J</given-names></name></person-group><source>The development and psychometric properties of LIWC 2007</source><year>2007</year><date-in-citation>2016-12-12</date-in-citation><publisher-loc>Austin</publisher-loc><publisher-name>University of Texas</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="http://www.liwc.net/LIWC2007LanguageManual.pdf">http://www.liwc.net/LIWC2007LanguageManual.pdf</ext-link><ext-link ext-link-type="webcite" xlink:href="6mhMjveun"></ext-link></comment></element-citation></ref><ref id="ref83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>MH</given-names></name><name><surname>Namdar</surname><given-names>AH</given-names></name><name><surname>Jouybari</surname><given-names>L</given-names></name></person-group><article-title>The efficacy of optimism: benefit finding in the treatment of diabetes in Iranian patients</article-title><source>ISRN Nurs</source><year>2014</year><volume>2014</volume><fpage>371296</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.1155/2014/371296"></ext-link></comment><pub-id pub-id-type="doi">10.1155/2014/371296</pub-id><pub-id pub-id-type="medline">25006496</pub-id><pub-id pub-id-type="pmid">25006496</pub-id></element-citation></ref><ref id="ref84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>AH</given-names></name></person-group><article-title>Does expressive writing reduce health care utilization? A meta-analysis of randomized trials</article-title><source>J Consult Clin Psychol</source><year>2006</year><month>4</month><volume>74</volume><issue>2</issue><fpage>243</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.74.2.243</pub-id><pub-id pub-id-type="medline">16649869</pub-id><pub-id pub-id-type="pmid">16649869</pub-id></element-citation></ref></ref-list></back></article>